A40.3
|
Sepsis due to Streptococcus pneumoniae
|
A40.9
|
Streptococcal sepsis, unspecified
|
A41.01
|
Sepsis due to Methicillin susceptible Staphylococcus aureus
|
A41.02
|
Sepsis due to Methicillin resistant Staphylococcus aureus
|
A41.1
|
Sepsis due to other specified staphylococcus
|
A41.2
|
Sepsis due to unspecified staphylococcus
|
A41.3
|
Sepsis due to Hemophilus influenzae
|
A41.4
|
Sepsis due to anaerobes
|
A41.50
|
Gram-negative sepsis, unspecified
|
A41.51
|
Sepsis due to Escherichia coli [E. coli]
|
A41.52
|
Sepsis due to Pseudomonas
|
A41.53
|
Sepsis due to Serratia
|
A41.54
|
Sepsis due to Acinetobacter baumannii
|
A41.59
|
Other Gram-negative sepsis
|
A41.89*
|
Other specified sepsis
|
A41.9*
|
Sepsis, unspecified organism
|
E00.0
|
Congenital iodine-deficiency syndrome, neurological type
|
E00.1
|
Congenital iodine-deficiency syndrome, myxedematous type
|
E00.2
|
Congenital iodine-deficiency syndrome, mixed type
|
E00.9
|
Congenital iodine-deficiency syndrome, unspecified
|
E01.8
|
Other iodine-deficiency related thyroid disorders and allied conditions
|
E02
|
Subclinical iodine-deficiency hypothyroidism
|
E03.0
|
Congenital hypothyroidism with diffuse goiter
|
E03.1
|
Congenital hypothyroidism without goiter
|
E03.2
|
Hypothyroidism due to medicaments and other exogenous substances
|
E03.3
|
Postinfectious hypothyroidism
|
E03.8
|
Other specified hypothyroidism
|
E03.9
|
Hypothyroidism, unspecified
|
E05.00
|
Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm
|
E05.01
|
Thyrotoxicosis with diffuse goiter with thyrotoxic crisis or storm
|
E05.10
|
Thyrotoxicosis with toxic single thyroid nodule without thyrotoxic crisis or storm
|
E05.11
|
Thyrotoxicosis with toxic single thyroid nodule with thyrotoxic crisis or storm
|
E05.20
|
Thyrotoxicosis with toxic multinodular goiter without thyrotoxic crisis or storm
|
E05.21
|
Thyrotoxicosis with toxic multinodular goiter with thyrotoxic crisis or storm
|
E05.30
|
Thyrotoxicosis from ectopic thyroid tissue without thyrotoxic crisis or storm
|
E05.31
|
Thyrotoxicosis from ectopic thyroid tissue with thyrotoxic crisis or storm
|
E05.40
|
Thyrotoxicosis factitia without thyrotoxic crisis or storm
|
E05.41
|
Thyrotoxicosis factitia with thyrotoxic crisis or storm
|
E05.80
|
Other thyrotoxicosis without thyrotoxic crisis or storm
|
E05.81
|
Other thyrotoxicosis with thyrotoxic crisis or storm
|
E05.90
|
Thyrotoxicosis, unspecified without thyrotoxic crisis or storm
|
E05.91
|
Thyrotoxicosis, unspecified with thyrotoxic crisis or storm
|
E10.10
|
Type 1 diabetes mellitus with ketoacidosis without coma
|
E10.11
|
Type 1 diabetes mellitus with ketoacidosis with coma
|
E10.21
|
Type 1 diabetes mellitus with diabetic nephropathy
|
E10.22
|
Type 1 diabetes mellitus with diabetic chronic kidney disease
|
E10.29
|
Type 1 diabetes mellitus with other diabetic kidney complication
|
E10.311
|
Type 1 diabetes mellitus with unspecified diabetic retinopathy with macular edema
|
E10.319
|
Type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema
|
E10.36
|
Type 1 diabetes mellitus with diabetic cataract
|
E10.39
|
Type 1 diabetes mellitus with other diabetic ophthalmic complication
|
E10.40
|
Type 1 diabetes mellitus with diabetic neuropathy, unspecified
|
E10.49
|
Type 1 diabetes mellitus with other diabetic neurological complication
|
E10.51
|
Type 1 diabetes mellitus with diabetic peripheral angiopathy without gangrene
|
E10.59
|
Type 1 diabetes mellitus with other circulatory complications
|
E10.618
|
Type 1 diabetes mellitus with other diabetic arthropathy
|
E10.620
|
Type 1 diabetes mellitus with diabetic dermatitis
|
E10.621
|
Type 1 diabetes mellitus with foot ulcer
|
E10.622
|
Type 1 diabetes mellitus with other skin ulcer
|
E10.628
|
Type 1 diabetes mellitus with other skin complications
|
E10.630
|
Type 1 diabetes mellitus with periodontal disease
|
E10.638
|
Type 1 diabetes mellitus with other oral complications
|
E10.641
|
Type 1 diabetes mellitus with hypoglycemia with coma
|
E10.649
|
Type 1 diabetes mellitus with hypoglycemia without coma
|
E10.65
|
Type 1 diabetes mellitus with hyperglycemia
|
E10.69
|
Type 1 diabetes mellitus with other specified complication
|
E10.8
|
Type 1 diabetes mellitus with unspecified complications
|
E10.9
|
Type 1 diabetes mellitus without complications
|
E11.00
|
Type 2 diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
|
E11.01
|
Type 2 diabetes mellitus with hyperosmolarity with coma
|
E11.10
|
Type 2 diabetes mellitus with ketoacidosis without coma
|
E11.11
|
Type 2 diabetes mellitus with ketoacidosis with coma
|
E11.21
|
Type 2 diabetes mellitus with diabetic nephropathy
|
E11.22
|
Type 2 diabetes mellitus with diabetic chronic kidney disease
|
E11.29
|
Type 2 diabetes mellitus with other diabetic kidney complication
|
E11.311
|
Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema
|
E11.319
|
Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema
|
E11.36
|
Type 2 diabetes mellitus with diabetic cataract
|
E11.39
|
Type 2 diabetes mellitus with other diabetic ophthalmic complication
|
E11.40
|
Type 2 diabetes mellitus with diabetic neuropathy, unspecified
|
E11.49
|
Type 2 diabetes mellitus with other diabetic neurological complication
|
E11.51
|
Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene
|
E11.59
|
Type 2 diabetes mellitus with other circulatory complications
|
E11.618
|
Type 2 diabetes mellitus with other diabetic arthropathy
|
E11.620
|
Type 2 diabetes mellitus with diabetic dermatitis
|
E11.621
|
Type 2 diabetes mellitus with foot ulcer
|
E11.622
|
Type 2 diabetes mellitus with other skin ulcer
|
E11.628
|
Type 2 diabetes mellitus with other skin complications
|
E11.630
|
Type 2 diabetes mellitus with periodontal disease
|
E11.638
|
Type 2 diabetes mellitus with other oral complications
|
E11.641
|
Type 2 diabetes mellitus with hypoglycemia with coma
|
E11.649
|
Type 2 diabetes mellitus with hypoglycemia without coma
|
E11.65
|
Type 2 diabetes mellitus with hyperglycemia
|
E11.69
|
Type 2 diabetes mellitus with other specified complication
|
E11.8
|
Type 2 diabetes mellitus with unspecified complications
|
E11.9
|
Type 2 diabetes mellitus without complications
|
E13.00
|
Other specified diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
|
E13.01
|
Other specified diabetes mellitus with hyperosmolarity with coma
|
E13.10
|
Other specified diabetes mellitus with ketoacidosis without coma
|
E13.11
|
Other specified diabetes mellitus with ketoacidosis with coma
|
E13.21
|
Other specified diabetes mellitus with diabetic nephropathy
|
E13.22
|
Other specified diabetes mellitus with diabetic chronic kidney disease
|
E13.29
|
Other specified diabetes mellitus with other diabetic kidney complication
|
E13.39
|
Other specified diabetes mellitus with other diabetic ophthalmic complication
|
E13.40
|
Other specified diabetes mellitus with diabetic neuropathy, unspecified
|
E13.49
|
Other specified diabetes mellitus with other diabetic neurological complication
|
E13.59
|
Other specified diabetes mellitus with other circulatory complications
|
E13.620
|
Other specified diabetes mellitus with diabetic dermatitis
|
E13.621
|
Other specified diabetes mellitus with foot ulcer
|
E13.622
|
Other specified diabetes mellitus with other skin ulcer
|
E13.628
|
Other specified diabetes mellitus with other skin complications
|
E13.638
|
Other specified diabetes mellitus with other oral complications
|
E13.641
|
Other specified diabetes mellitus with hypoglycemia with coma
|
E13.649
|
Other specified diabetes mellitus with hypoglycemia without coma
|
E13.65
|
Other specified diabetes mellitus with hyperglycemia
|
E13.69
|
Other specified diabetes mellitus with other specified complication
|
E13.8
|
Other specified diabetes mellitus with unspecified complications
|
E13.9
|
Other specified diabetes mellitus without complications
|
E15
|
Nondiabetic hypoglycemic coma
|
E16.0
|
Drug-induced hypoglycemia without coma
|
E16.1
|
Other hypoglycemia
|
E16.2
|
Hypoglycemia, unspecified
|
E16.3
|
Increased secretion of glucagon
|
E16.4
|
Increased secretion of gastrin
|
E16.8
|
Other specified disorders of pancreatic internal secretion
|
E16.9
|
Disorder of pancreatic internal secretion, unspecified
|
E16.A1
|
Hypoglycemia level 1
|
E16.A2
|
Hypoglycemia level 2
|
E16.A3
|
Hypoglycemia level 3
|
E20.0
|
Idiopathic hypoparathyroidism
|
E20.810
|
Autosomal dominant hypocalcemia
|
E20.811
|
Secondary hypoparathyroidism in diseases classified elsewhere
|
E20.812
|
Autoimmune hypoparathyroidism
|
E20.818
|
Other specified hypoparathyroidism due to impaired parathyroid hormone secretion
|
E20.89
|
Other specified hypoparathyroidism
|
E20.9
|
Hypoparathyroidism, unspecified
|
E21.0
|
Primary hyperparathyroidism
|
E21.1
|
Secondary hyperparathyroidism, not elsewhere classified
|
E21.2
|
Other hyperparathyroidism
|
E21.3
|
Hyperparathyroidism, unspecified
|
E21.4
|
Other specified disorders of parathyroid gland
|
E21.5
|
Disorder of parathyroid gland, unspecified
|
E22.0
|
Acromegaly and pituitary gigantism
|
E22.1
|
Hyperprolactinemia
|
E22.2
|
Syndrome of inappropriate secretion of antidiuretic hormone
|
E22.8
|
Other hyperfunction of pituitary gland
|
E22.9
|
Hyperfunction of pituitary gland, unspecified
|
E23.0
|
Hypopituitarism
|
E23.1
|
Drug-induced hypopituitarism
|
E23.2
|
Diabetes insipidus
|
E23.3
|
Hypothalamic dysfunction, not elsewhere classified
|
E23.6
|
Other disorders of pituitary gland
|
E23.7
|
Disorder of pituitary gland, unspecified
|
E24.0
|
Pituitary-dependent Cushing's disease
|
E24.1
|
Nelson's syndrome
|
E24.2
|
Drug-induced Cushing's syndrome
|
E24.3
|
Ectopic ACTH syndrome
|
E24.4
|
Alcohol-induced pseudo-Cushing's syndrome
|
E24.8
|
Other Cushing's syndrome
|
E24.9
|
Cushing's syndrome, unspecified
|
E25.0
|
Congenital adrenogenital disorders associated with enzyme deficiency
|
E25.8
|
Other adrenogenital disorders
|
E25.9
|
Adrenogenital disorder, unspecified
|
E26.01
|
Conn's syndrome
|
E26.02
|
Glucocorticoid-remediable aldosteronism
|
E26.09
|
Other primary hyperaldosteronism
|
E26.1
|
Secondary hyperaldosteronism
|
E26.81
|
Bartter's syndrome
|
E26.89
|
Other hyperaldosteronism
|
E26.9
|
Hyperaldosteronism, unspecified
|
E27.0
|
Other adrenocortical overactivity
|
E27.1
|
Primary adrenocortical insufficiency
|
E27.2
|
Addisonian crisis
|
E27.3
|
Drug-induced adrenocortical insufficiency
|
E27.40
|
Unspecified adrenocortical insufficiency
|
E27.49
|
Other adrenocortical insufficiency
|
E27.5
|
Adrenomedullary hyperfunction
|
E27.8*
|
Other specified disorders of adrenal gland
|
E27.9*
|
Disorder of adrenal gland, unspecified
|
E32.0
|
Persistent hyperplasia of thymus
|
E32.1
|
Abscess of thymus
|
E32.8
|
Other diseases of thymus
|
E32.9
|
Disease of thymus, unspecified
|
E34.4
|
Constitutional tall stature
|
E35*
|
Disorders of endocrine glands in diseases classified elsewhere
|
E66.01*
|
Morbid (severe) obesity due to excess calories
|
E66.2
|
Morbid (severe) obesity with alveolar hypoventilation
|
E66.813*
|
Obesity, class 3
|
E84.0*
|
Cystic fibrosis with pulmonary manifestations
|
E84.11*
|
Meconium ileus in cystic fibrosis
|
E84.9*
|
Cystic fibrosis, unspecified
|
E86.0
|
Dehydration
|
E86.1
|
Hypovolemia
|
E86.9
|
Volume depletion, unspecified
|
E87.0
|
Hyperosmolality and hypernatremia
|
E87.1
|
Hypo-osmolality and hyponatremia
|
E87.20
|
Acidosis, unspecified
|
E87.21
|
Acute metabolic acidosis
|
E87.22
|
Chronic metabolic acidosis
|
E87.29
|
Other acidosis
|
E87.3
|
Alkalosis
|
E87.4
|
Mixed disorder of acid-base balance
|
E87.5*
|
Hyperkalemia
|
E87.6*
|
Hypokalemia
|
E87.70
|
Fluid overload, unspecified
|
E87.71
|
Transfusion associated circulatory overload
|
E87.79
|
Other fluid overload
|
E87.8*
|
Other disorders of electrolyte and fluid balance, not elsewhere classified
|
E89.0
|
Postprocedural hypothyroidism
|
E89.1
|
Postprocedural hypoinsulinemia
|
E89.2
|
Postprocedural hypoparathyroidism
|
E89.3
|
Postprocedural hypopituitarism
|
E89.6
|
Postprocedural adrenocortical (-medullary) hypofunction
|
F01.50
|
Vascular dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
F01.511
|
Vascular dementia, unspecified severity, with agitation
|
F01.518
|
Vascular dementia, unspecified severity, with other behavioral disturbance
|
F01.52
|
Vascular dementia, unspecified severity, with psychotic disturbance
|
F01.53
|
Vascular dementia, unspecified severity, with mood disturbance
|
F01.54
|
Vascular dementia, unspecified severity, with anxiety
|
F01.A0
|
Vascular dementia, mild, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
F01.A11
|
Vascular dementia, mild, with agitation
|
F01.A18
|
Vascular dementia, mild, with other behavioral disturbance
|
F01.A2
|
Vascular dementia, mild, with psychotic disturbance
|
F01.A3
|
Vascular dementia, mild, with mood disturbance
|
F01.A4
|
Vascular dementia, mild, with anxiety
|
F01.B0
|
Vascular dementia, moderate, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
F01.B11
|
Vascular dementia, moderate, with agitation
|
F01.B18
|
Vascular dementia, moderate, with other behavioral disturbance
|
F01.B2
|
Vascular dementia, moderate, with psychotic disturbance
|
F01.B3
|
Vascular dementia, moderate, with mood disturbance
|
F01.B4
|
Vascular dementia, moderate, with anxiety
|
F01.C0
|
Vascular dementia, severe, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
F01.C11
|
Vascular dementia, severe, with agitation
|
F01.C18
|
Vascular dementia, severe, with other behavioral disturbance
|
F01.C2
|
Vascular dementia, severe, with psychotic disturbance
|
F01.C3
|
Vascular dementia, severe, with mood disturbance
|
F01.C4
|
Vascular dementia, severe, with anxiety
|
F02.80
|
Dementia in other diseases classified elsewhere, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
F02.811
|
Dementia in other diseases classified elsewhere, unspecified severity, with agitation
|
F02.818
|
Dementia in other diseases classified elsewhere, unspecified severity, with other behavioral disturbance
|
F02.82
|
Dementia in other diseases classified elsewhere, unspecified severity, with psychotic disturbance
|
F02.83
|
Dementia in other diseases classified elsewhere, unspecified severity, with mood disturbance
|
F02.84
|
Dementia in other diseases classified elsewhere, unspecified severity, with anxiety
|
F02.A0
|
Dementia in other diseases classified elsewhere, mild, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
F02.A11
|
Dementia in other diseases classified elsewhere, mild, with agitation
|
F02.A18
|
Dementia in other diseases classified elsewhere, mild, with other behavioral disturbance
|
F02.A2
|
Dementia in other diseases classified elsewhere, mild, with psychotic disturbance
|
F02.A3
|
Dementia in other diseases classified elsewhere, mild, with mood disturbance
|
F02.A4
|
Dementia in other diseases classified elsewhere, mild, with anxiety
|
F02.B0
|
Dementia in other diseases classified elsewhere, moderate, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
F02.B11
|
Dementia in other diseases classified elsewhere, moderate, with agitation
|
F02.B18
|
Dementia in other diseases classified elsewhere, moderate, with other behavioral disturbance
|
F02.B2
|
Dementia in other diseases classified elsewhere, moderate, with psychotic disturbance
|
F02.B3
|
Dementia in other diseases classified elsewhere, moderate, with mood disturbance
|
F02.B4
|
Dementia in other diseases classified elsewhere, moderate, with anxiety
|
F02.C0
|
Dementia in other diseases classified elsewhere, severe, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
F02.C11
|
Dementia in other diseases classified elsewhere, severe, with agitation
|
F02.C18
|
Dementia in other diseases classified elsewhere, severe, with other behavioral disturbance
|
F02.C2
|
Dementia in other diseases classified elsewhere, severe, with psychotic disturbance
|
F02.C3
|
Dementia in other diseases classified elsewhere, severe, with mood disturbance
|
F02.C4
|
Dementia in other diseases classified elsewhere, severe, with anxiety
|
F03.90
|
Unspecified dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
F03.911
|
Unspecified dementia, unspecified severity, with agitation
|
F03.918
|
Unspecified dementia, unspecified severity, with other behavioral disturbance
|
F03.92
|
Unspecified dementia, unspecified severity, with psychotic disturbance
|
F03.93
|
Unspecified dementia, unspecified severity, with mood disturbance
|
F03.94
|
Unspecified dementia, unspecified severity, with anxiety
|
F03.A0
|
Unspecified dementia, mild, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
F03.A11
|
Unspecified dementia, mild, with agitation
|
F03.A18
|
Unspecified dementia, mild, with other behavioral disturbance
|
F03.A2
|
Unspecified dementia, mild, with psychotic disturbance
|
F03.A3
|
Unspecified dementia, mild, with mood disturbance
|
F03.A4
|
Unspecified dementia, mild, with anxiety
|
F03.B0
|
Unspecified dementia, moderate, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
F03.B11
|
Unspecified dementia, moderate, with agitation
|
F03.B18
|
Unspecified dementia, moderate, with other behavioral disturbance
|
F03.B2
|
Unspecified dementia, moderate, with psychotic disturbance
|
F03.B3
|
Unspecified dementia, moderate, with mood disturbance
|
F03.B4
|
Unspecified dementia, moderate, with anxiety
|
F03.C0
|
Unspecified dementia, severe, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
F03.C11
|
Unspecified dementia, severe, with agitation
|
F03.C18
|
Unspecified dementia, severe, with other behavioral disturbance
|
F03.C2
|
Unspecified dementia, severe, with psychotic disturbance
|
F03.C3
|
Unspecified dementia, severe, with mood disturbance
|
F03.C4
|
Unspecified dementia, severe, with anxiety
|
F04
|
Amnestic disorder due to known physiological condition
|
F05
|
Delirium due to known physiological condition
|
F06.0
|
Psychotic disorder with hallucinations due to known physiological condition
|
F06.1
|
Catatonic disorder due to known physiological condition
|
F06.2
|
Psychotic disorder with delusions due to known physiological condition
|
F06.30
|
Mood disorder due to known physiological condition, unspecified
|
F06.31
|
Mood disorder due to known physiological condition with depressive features
|
F06.32
|
Mood disorder due to known physiological condition with major depressive-like episode
|
F06.33
|
Mood disorder due to known physiological condition with manic features
|
F06.34
|
Mood disorder due to known physiological condition with mixed features
|
F06.4
|
Anxiety disorder due to known physiological condition
|
F06.8
|
Other specified mental disorders due to known physiological condition
|
F10.10*
|
Alcohol abuse, uncomplicated
|
F10.120*
|
Alcohol abuse with intoxication, uncomplicated
|
F10.121
|
Alcohol abuse with intoxication delirium
|
F10.129*
|
Alcohol abuse with intoxication, unspecified
|
F10.14
|
Alcohol abuse with alcohol-induced mood disorder
|
F10.150
|
Alcohol abuse with alcohol-induced psychotic disorder with delusions
|
F10.151
|
Alcohol abuse with alcohol-induced psychotic disorder with hallucinations
|
F10.159
|
Alcohol abuse with alcohol-induced psychotic disorder, unspecified
|
F10.180
|
Alcohol abuse with alcohol-induced anxiety disorder
|
F10.181
|
Alcohol abuse with alcohol-induced sexual dysfunction
|
F10.188
|
Alcohol abuse with other alcohol-induced disorder
|
F10.19
|
Alcohol abuse with unspecified alcohol-induced disorder
|
F10.221
|
Alcohol dependence with intoxication delirium
|
F10.230
|
Alcohol dependence with withdrawal, uncomplicated
|
F10.231
|
Alcohol dependence with withdrawal delirium
|
F10.232
|
Alcohol dependence with withdrawal with perceptual disturbance
|
F10.239
|
Alcohol dependence with withdrawal, unspecified
|
F10.24
|
Alcohol dependence with alcohol-induced mood disorder
|
F10.250
|
Alcohol dependence with alcohol-induced psychotic disorder with delusions
|
F10.251
|
Alcohol dependence with alcohol-induced psychotic disorder with hallucinations
|
F10.259
|
Alcohol dependence with alcohol-induced psychotic disorder, unspecified
|
F10.26
|
Alcohol dependence with alcohol-induced persisting amnestic disorder
|
F10.27
|
Alcohol dependence with alcohol-induced persisting dementia
|
F10.280
|
Alcohol dependence with alcohol-induced anxiety disorder
|
F10.281
|
Alcohol dependence with alcohol-induced sexual dysfunction
|
F10.288
|
Alcohol dependence with other alcohol-induced disorder
|
F10.29
|
Alcohol dependence with unspecified alcohol-induced disorder
|
F10.920
|
Alcohol use, unspecified with intoxication, uncomplicated
|
F10.921
|
Alcohol use, unspecified with intoxication delirium
|
F10.929
|
Alcohol use, unspecified with intoxication, unspecified
|
F10.94
|
Alcohol use, unspecified with alcohol-induced mood disorder
|
F10.950
|
Alcohol use, unspecified with alcohol-induced psychotic disorder with delusions
|
F10.951
|
Alcohol use, unspecified with alcohol-induced psychotic disorder with hallucinations
|
F10.959
|
Alcohol use, unspecified with alcohol-induced psychotic disorder, unspecified
|
F10.96
|
Alcohol use, unspecified with alcohol-induced persisting amnestic disorder
|
F10.97
|
Alcohol use, unspecified with alcohol-induced persisting dementia
|
F10.980
|
Alcohol use, unspecified with alcohol-induced anxiety disorder
|
F10.981
|
Alcohol use, unspecified with alcohol-induced sexual dysfunction
|
F10.988
|
Alcohol use, unspecified with other alcohol-induced disorder
|
F10.99
|
Alcohol use, unspecified with unspecified alcohol-induced disorder
|
F11.10
|
Opioid abuse, uncomplicated
|
F11.120
|
Opioid abuse with intoxication, uncomplicated
|
F11.121
|
Opioid abuse with intoxication delirium
|
F11.122
|
Opioid abuse with intoxication with perceptual disturbance
|
F11.129
|
Opioid abuse with intoxication, unspecified
|
F11.14
|
Opioid abuse with opioid-induced mood disorder
|
F11.150
|
Opioid abuse with opioid-induced psychotic disorder with delusions
|
F11.151
|
Opioid abuse with opioid-induced psychotic disorder with hallucinations
|
F11.159
|
Opioid abuse with opioid-induced psychotic disorder, unspecified
|
F11.181
|
Opioid abuse with opioid-induced sexual dysfunction
|
F11.188
|
Opioid abuse with other opioid-induced disorder
|
F11.19
|
Opioid abuse with unspecified opioid-induced disorder
|
F11.20
|
Opioid dependence, uncomplicated
|
F11.21
|
Opioid dependence, in remission
|
F11.222
|
Opioid dependence with intoxication with perceptual disturbance
|
F11.259
|
Opioid dependence with opioid-induced psychotic disorder, unspecified
|
F11.281
|
Opioid dependence with opioid-induced sexual dysfunction
|
F11.288
|
Opioid dependence with other opioid-induced disorder
|
F11.90
|
Opioid use, unspecified, uncomplicated
|
F11.920
|
Opioid use, unspecified with intoxication, uncomplicated
|
F11.921
|
Opioid use, unspecified with intoxication delirium
|
F11.922
|
Opioid use, unspecified with intoxication with perceptual disturbance
|
F11.929
|
Opioid use, unspecified with intoxication, unspecified
|
F11.93
|
Opioid use, unspecified with withdrawal
|
F11.94
|
Opioid use, unspecified with opioid-induced mood disorder
|
F11.950
|
Opioid use, unspecified with opioid-induced psychotic disorder with delusions
|
F11.951
|
Opioid use, unspecified with opioid-induced psychotic disorder with hallucinations
|
F11.959
|
Opioid use, unspecified with opioid-induced psychotic disorder, unspecified
|
F11.981
|
Opioid use, unspecified with opioid-induced sexual dysfunction
|
F11.988
|
Opioid use, unspecified with other opioid-induced disorder
|
F11.99
|
Opioid use, unspecified with unspecified opioid-induced disorder
|
F12.10
|
Cannabis abuse, uncomplicated
|
F12.120
|
Cannabis abuse with intoxication, uncomplicated
|
F12.121
|
Cannabis abuse with intoxication delirium
|
F12.122
|
Cannabis abuse with intoxication with perceptual disturbance
|
F12.129
|
Cannabis abuse with intoxication, unspecified
|
F12.150
|
Cannabis abuse with psychotic disorder with delusions
|
F12.151
|
Cannabis abuse with psychotic disorder with hallucinations
|
F12.159
|
Cannabis abuse with psychotic disorder, unspecified
|
F12.180
|
Cannabis abuse with cannabis-induced anxiety disorder
|
F12.188
|
Cannabis abuse with other cannabis-induced disorder
|
F12.19
|
Cannabis abuse with unspecified cannabis-induced disorder
|
F12.20
|
Cannabis dependence, uncomplicated
|
F12.21
|
Cannabis dependence, in remission
|
F12.222
|
Cannabis dependence with intoxication with perceptual disturbance
|
F12.23
|
Cannabis dependence with withdrawal
|
F12.259
|
Cannabis dependence with psychotic disorder, unspecified
|
F12.280
|
Cannabis dependence with cannabis-induced anxiety disorder
|
F12.288
|
Cannabis dependence with other cannabis-induced disorder
|
F12.90
|
Cannabis use, unspecified, uncomplicated
|
F12.920
|
Cannabis use, unspecified with intoxication, uncomplicated
|
F12.921
|
Cannabis use, unspecified with intoxication delirium
|
F12.922
|
Cannabis use, unspecified with intoxication with perceptual disturbance
|
F12.929
|
Cannabis use, unspecified with intoxication, unspecified
|
F12.93
|
Cannabis use, unspecified with withdrawal
|
F12.950
|
Cannabis use, unspecified with psychotic disorder with delusions
|
F12.951
|
Cannabis use, unspecified with psychotic disorder with hallucinations
|
F12.959
|
Cannabis use, unspecified with psychotic disorder, unspecified
|
F12.980
|
Cannabis use, unspecified with anxiety disorder
|
F12.988
|
Cannabis use, unspecified with other cannabis-induced disorder
|
F12.99
|
Cannabis use, unspecified with unspecified cannabis-induced disorder
|
F13.10
|
Sedative, hypnotic or anxiolytic abuse, uncomplicated
|
F13.120
|
Sedative, hypnotic or anxiolytic abuse with intoxication, uncomplicated
|
F13.121
|
Sedative, hypnotic or anxiolytic abuse with intoxication delirium
|
F13.129
|
Sedative, hypnotic or anxiolytic abuse with intoxication, unspecified
|
F13.14
|
Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced mood disorder
|
F13.150
|
Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions
|
F13.151
|
Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations
|
F13.159
|
Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified
|
F13.180
|
Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced anxiety disorder
|
F13.181
|
Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sexual dysfunction
|
F13.188
|
Sedative, hypnotic or anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced disorder
|
F13.19
|
Sedative, hypnotic or anxiolytic abuse with unspecified sedative, hypnotic or anxiolytic-induced disorder
|
F13.20
|
Sedative, hypnotic or anxiolytic dependence, uncomplicated
|
F13.21
|
Sedative, hypnotic or anxiolytic dependence, in remission
|
F13.259
|
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified
|
F13.280
|
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced anxiety disorder
|
F13.281
|
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sexual dysfunction
|
F13.288
|
Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or anxiolytic-induced disorder
|
F13.90
|
Sedative, hypnotic, or anxiolytic use, unspecified, uncomplicated
|
F13.920
|
Sedative, hypnotic or anxiolytic use, unspecified with intoxication, uncomplicated
|
F13.921
|
Sedative, hypnotic or anxiolytic use, unspecified with intoxication delirium
|
F13.929
|
Sedative, hypnotic or anxiolytic use, unspecified with intoxication, unspecified
|
F13.930
|
Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, uncomplicated
|
F13.931
|
Sedative, hypnotic or anxiolytic use, unspecified with withdrawal delirium
|
F13.932
|
Sedative, hypnotic or anxiolytic use, unspecified with withdrawal with perceptual disturbances
|
F13.939
|
Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, unspecified
|
F13.94
|
Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced mood disorder
|
F13.950
|
Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions
|
F13.951
|
Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations
|
F13.959
|
Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified
|
F13.96
|
Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder
|
F13.97
|
Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting dementia
|
F13.980
|
Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder
|
F13.981
|
Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sexual dysfunction
|
F13.988
|
Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorder
|
F13.99
|
Sedative, hypnotic or anxiolytic use, unspecified with unspecified sedative, hypnotic or anxiolytic-induced disorder
|
F14.10
|
Cocaine abuse, uncomplicated
|
F14.120
|
Cocaine abuse with intoxication, uncomplicated
|
F14.121
|
Cocaine abuse with intoxication with delirium
|
F14.122
|
Cocaine abuse with intoxication with perceptual disturbance
|
F14.129
|
Cocaine abuse with intoxication, unspecified
|
F14.14
|
Cocaine abuse with cocaine-induced mood disorder
|
F14.150
|
Cocaine abuse with cocaine-induced psychotic disorder with delusions
|
F14.151
|
Cocaine abuse with cocaine-induced psychotic disorder with hallucinations
|
F14.159
|
Cocaine abuse with cocaine-induced psychotic disorder, unspecified
|
F14.180
|
Cocaine abuse with cocaine-induced anxiety disorder
|
F14.181
|
Cocaine abuse with cocaine-induced sexual dysfunction
|
F14.188
|
Cocaine abuse with other cocaine-induced disorder
|
F14.19
|
Cocaine abuse with unspecified cocaine-induced disorder
|
F14.20
|
Cocaine dependence, uncomplicated
|
F14.21
|
Cocaine dependence, in remission
|
F14.222
|
Cocaine dependence with intoxication with perceptual disturbance
|
F14.259
|
Cocaine dependence with cocaine-induced psychotic disorder, unspecified
|
F14.280
|
Cocaine dependence with cocaine-induced anxiety disorder
|
F14.281
|
Cocaine dependence with cocaine-induced sexual dysfunction
|
F14.288
|
Cocaine dependence with other cocaine-induced disorder
|
F14.90
|
Cocaine use, unspecified, uncomplicated
|
F14.920
|
Cocaine use, unspecified with intoxication, uncomplicated
|
F14.921
|
Cocaine use, unspecified with intoxication delirium
|
F14.922
|
Cocaine use, unspecified with intoxication with perceptual disturbance
|
F14.929
|
Cocaine use, unspecified with intoxication, unspecified
|
F14.94
|
Cocaine use, unspecified with cocaine-induced mood disorder
|
F14.950
|
Cocaine use, unspecified with cocaine-induced psychotic disorder with delusions
|
F14.951
|
Cocaine use, unspecified with cocaine-induced psychotic disorder with hallucinations
|
F14.959
|
Cocaine use, unspecified with cocaine-induced psychotic disorder, unspecified
|
F14.980
|
Cocaine use, unspecified with cocaine-induced anxiety disorder
|
F14.981
|
Cocaine use, unspecified with cocaine-induced sexual dysfunction
|
F14.988
|
Cocaine use, unspecified with other cocaine-induced disorder
|
F14.99
|
Cocaine use, unspecified with unspecified cocaine-induced disorder
|
F15.10
|
Other stimulant abuse, uncomplicated
|
F15.120
|
Other stimulant abuse with intoxication, uncomplicated
|
F15.121
|
Other stimulant abuse with intoxication delirium
|
F15.122
|
Other stimulant abuse with intoxication with perceptual disturbance
|
F15.129
|
Other stimulant abuse with intoxication, unspecified
|
F15.14
|
Other stimulant abuse with stimulant-induced mood disorder
|
F15.150
|
Other stimulant abuse with stimulant-induced psychotic disorder with delusions
|
F15.151
|
Other stimulant abuse with stimulant-induced psychotic disorder with hallucinations
|
F15.159
|
Other stimulant abuse with stimulant-induced psychotic disorder, unspecified
|
F15.180
|
Other stimulant abuse with stimulant-induced anxiety disorder
|
F15.181
|
Other stimulant abuse with stimulant-induced sexual dysfunction
|
F15.188
|
Other stimulant abuse with other stimulant-induced disorder
|
F15.19
|
Other stimulant abuse with unspecified stimulant-induced disorder
|
F15.20
|
Other stimulant dependence, uncomplicated
|
F15.21
|
Other stimulant dependence, in remission
|
F15.222
|
Other stimulant dependence with intoxication with perceptual disturbance
|
F15.259
|
Other stimulant dependence with stimulant-induced psychotic disorder, unspecified
|
F15.280
|
Other stimulant dependence with stimulant-induced anxiety disorder
|
F15.281
|
Other stimulant dependence with stimulant-induced sexual dysfunction
|
F15.288
|
Other stimulant dependence with other stimulant-induced disorder
|
F15.90
|
Other stimulant use, unspecified, uncomplicated
|
F15.920
|
Other stimulant use, unspecified with intoxication, uncomplicated
|
F15.921
|
Other stimulant use, unspecified with intoxication delirium
|
F15.922
|
Other stimulant use, unspecified with intoxication with perceptual disturbance
|
F15.929
|
Other stimulant use, unspecified with intoxication, unspecified
|
F15.93
|
Other stimulant use, unspecified with withdrawal
|
F15.94
|
Other stimulant use, unspecified with stimulant-induced mood disorder
|
F15.950
|
Other stimulant use, unspecified with stimulant-induced psychotic disorder with delusions
|
F15.951
|
Other stimulant use, unspecified with stimulant-induced psychotic disorder with hallucinations
|
F15.959
|
Other stimulant use, unspecified with stimulant-induced psychotic disorder, unspecified
|
F15.980
|
Other stimulant use, unspecified with stimulant-induced anxiety disorder
|
F15.981
|
Other stimulant use, unspecified with stimulant-induced sexual dysfunction
|
F15.988
|
Other stimulant use, unspecified with other stimulant-induced disorder
|
F15.99
|
Other stimulant use, unspecified with unspecified stimulant-induced disorder
|
F16.10
|
Hallucinogen abuse, uncomplicated
|
F16.120
|
Hallucinogen abuse with intoxication, uncomplicated
|
F16.121
|
Hallucinogen abuse with intoxication with delirium
|
F16.122
|
Hallucinogen abuse with intoxication with perceptual disturbance
|
F16.129
|
Hallucinogen abuse with intoxication, unspecified
|
F16.14
|
Hallucinogen abuse with hallucinogen-induced mood disorder
|
F16.150
|
Hallucinogen abuse with hallucinogen-induced psychotic disorder with delusions
|
F16.151
|
Hallucinogen abuse with hallucinogen-induced psychotic disorder with hallucinations
|
F16.159
|
Hallucinogen abuse with hallucinogen-induced psychotic disorder, unspecified
|
F16.180
|
Hallucinogen abuse with hallucinogen-induced anxiety disorder
|
F16.183
|
Hallucinogen abuse with hallucinogen persisting perception disorder (flashbacks)
|
F16.188
|
Hallucinogen abuse with other hallucinogen-induced disorder
|
F16.19
|
Hallucinogen abuse with unspecified hallucinogen-induced disorder
|
F16.20
|
Hallucinogen dependence, uncomplicated
|
F16.21
|
Hallucinogen dependence, in remission
|
F16.259
|
Hallucinogen dependence with hallucinogen-induced psychotic disorder, unspecified
|
F16.280
|
Hallucinogen dependence with hallucinogen-induced anxiety disorder
|
F16.283
|
Hallucinogen dependence with hallucinogen persisting perception disorder (flashbacks)
|
F16.288
|
Hallucinogen dependence with other hallucinogen-induced disorder
|
F16.90
|
Hallucinogen use, unspecified, uncomplicated
|
F16.920
|
Hallucinogen use, unspecified with intoxication, uncomplicated
|
F16.921
|
Hallucinogen use, unspecified with intoxication with delirium
|
F16.929
|
Hallucinogen use, unspecified with intoxication, unspecified
|
F16.94
|
Hallucinogen use, unspecified with hallucinogen-induced mood disorder
|
F16.950
|
Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with delusions
|
F16.951
|
Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with hallucinations
|
F16.959
|
Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder, unspecified
|
F16.980
|
Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder
|
F16.983
|
Hallucinogen use, unspecified with hallucinogen persisting perception disorder (flashbacks)
|
F16.988
|
Hallucinogen use, unspecified with other hallucinogen-induced disorder
|
F16.99
|
Hallucinogen use, unspecified with unspecified hallucinogen-induced disorder
|
F17.203
|
Nicotine dependence unspecified, with withdrawal
|
F17.208
|
Nicotine dependence, unspecified, with other nicotine-induced disorders
|
F17.209
|
Nicotine dependence, unspecified, with unspecified nicotine-induced disorders
|
F17.213
|
Nicotine dependence, cigarettes, with withdrawal
|
F17.218
|
Nicotine dependence, cigarettes, with other nicotine-induced disorders
|
F17.219
|
Nicotine dependence, cigarettes, with unspecified nicotine-induced disorders
|
F17.223
|
Nicotine dependence, chewing tobacco, with withdrawal
|
F17.228
|
Nicotine dependence, chewing tobacco, with other nicotine-induced disorders
|
F17.229
|
Nicotine dependence, chewing tobacco, with unspecified nicotine-induced disorders
|
F17.293
|
Nicotine dependence, other tobacco product, with withdrawal
|
F17.298
|
Nicotine dependence, other tobacco product, with other nicotine-induced disorders
|
F17.299
|
Nicotine dependence, other tobacco product, with unspecified nicotine-induced disorders
|
F18.120
|
Inhalant abuse with intoxication, uncomplicated
|
F18.121
|
Inhalant abuse with intoxication delirium
|
F18.129
|
Inhalant abuse with intoxication, unspecified
|
F18.14
|
Inhalant abuse with inhalant-induced mood disorder
|
F18.150
|
Inhalant abuse with inhalant-induced psychotic disorder with delusions
|
F18.151
|
Inhalant abuse with inhalant-induced psychotic disorder with hallucinations
|
F18.159
|
Inhalant abuse with inhalant-induced psychotic disorder, unspecified
|
F18.17
|
Inhalant abuse with inhalant-induced dementia
|
F18.180
|
Inhalant abuse with inhalant-induced anxiety disorder
|
F18.188
|
Inhalant abuse with other inhalant-induced disorder
|
F18.19
|
Inhalant abuse with unspecified inhalant-induced disorder
|
F18.20
|
Inhalant dependence, uncomplicated
|
F18.21
|
Inhalant dependence, in remission
|
F18.259
|
Inhalant dependence with inhalant-induced psychotic disorder, unspecified
|
F18.280
|
Inhalant dependence with inhalant-induced anxiety disorder
|
F18.288
|
Inhalant dependence with other inhalant-induced disorder
|
F18.920
|
Inhalant use, unspecified with intoxication, uncomplicated
|
F18.921
|
Inhalant use, unspecified with intoxication with delirium
|
F18.929
|
Inhalant use, unspecified with intoxication, unspecified
|
F18.94
|
Inhalant use, unspecified with inhalant-induced mood disorder
|
F18.950
|
Inhalant use, unspecified with inhalant-induced psychotic disorder with delusions
|
F18.951
|
Inhalant use, unspecified with inhalant-induced psychotic disorder with hallucinations
|
F18.959
|
Inhalant use, unspecified with inhalant-induced psychotic disorder, unspecified
|
F18.97
|
Inhalant use, unspecified with inhalant-induced persisting dementia
|
F18.980
|
Inhalant use, unspecified with inhalant-induced anxiety disorder
|
F18.988
|
Inhalant use, unspecified with other inhalant-induced disorder
|
F18.99
|
Inhalant use, unspecified with unspecified inhalant-induced disorder
|
F19.10*
|
Other psychoactive substance abuse, uncomplicated
|
F19.120*
|
Other psychoactive substance abuse with intoxication, uncomplicated
|
F19.121
|
Other psychoactive substance abuse with intoxication delirium
|
F19.122
|
Other psychoactive substance abuse with intoxication with perceptual disturbances
|
F19.129
|
Other psychoactive substance abuse with intoxication, unspecified
|
F19.14
|
Other psychoactive substance abuse with psychoactive substance-induced mood disorder
|
F19.150
|
Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with delusions
|
F19.151
|
Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with hallucinations
|
F19.159
|
Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder, unspecified
|
F19.16
|
Other psychoactive substance abuse with psychoactive substance-induced persisting amnestic disorder
|
F19.17
|
Other psychoactive substance abuse with psychoactive substance-induced persisting dementia
|
F19.180
|
Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder
|
F19.181
|
Other psychoactive substance abuse with psychoactive substance-induced sexual dysfunction
|
F19.188
|
Other psychoactive substance abuse with other psychoactive substance-induced disorder
|
F19.19
|
Other psychoactive substance abuse with unspecified psychoactive substance-induced disorder
|
F19.20*
|
Other psychoactive substance dependence, uncomplicated
|
F19.21*
|
Other psychoactive substance dependence, in remission
|
F19.222
|
Other psychoactive substance dependence with intoxication with perceptual disturbance
|
F19.259
|
Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder, unspecified
|
F19.280
|
Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder
|
F19.281
|
Other psychoactive substance dependence with psychoactive substance-induced sexual dysfunction
|
F19.288
|
Other psychoactive substance dependence with other psychoactive substance-induced disorder
|
F19.90*
|
Other psychoactive substance use, unspecified, uncomplicated
|
F19.920
|
Other psychoactive substance use, unspecified with intoxication, uncomplicated
|
F19.921
|
Other psychoactive substance use, unspecified with intoxication with delirium
|
F19.922
|
Other psychoactive substance use, unspecified with intoxication with perceptual disturbance
|
F19.929
|
Other psychoactive substance use, unspecified with intoxication, unspecified
|
F19.930
|
Other psychoactive substance use, unspecified with withdrawal, uncomplicated
|
F19.931
|
Other psychoactive substance use, unspecified with withdrawal delirium
|
F19.932
|
Other psychoactive substance use, unspecified with withdrawal with perceptual disturbance
|
F19.939
|
Other psychoactive substance use, unspecified with withdrawal, unspecified
|
F19.94
|
Other psychoactive substance use, unspecified with psychoactive substance-induced mood disorder
|
F19.950
|
Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with delusions
|
F19.951
|
Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with hallucinations
|
F19.959
|
Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder, unspecified
|
F19.96
|
Other psychoactive substance use, unspecified with psychoactive substance-induced persisting amnestic disorder
|
F19.97
|
Other psychoactive substance use, unspecified with psychoactive substance-induced persisting dementia
|
F19.980
|
Other psychoactive substance use, unspecified with psychoactive substance-induced anxiety disorder
|
F19.981
|
Other psychoactive substance use, unspecified with psychoactive substance-induced sexual dysfunction
|
F19.988
|
Other psychoactive substance use, unspecified with other psychoactive substance-induced disorder
|
F19.99
|
Other psychoactive substance use, unspecified with unspecified psychoactive substance-induced disorder
|
F20.0
|
Paranoid schizophrenia
|
F20.1
|
Disorganized schizophrenia
|
F20.2
|
Catatonic schizophrenia
|
F20.3
|
Undifferentiated schizophrenia
|
F20.5
|
Residual schizophrenia
|
F20.81
|
Schizophreniform disorder
|
F20.89
|
Other schizophrenia
|
F20.9
|
Schizophrenia, unspecified
|
F22
|
Delusional disorders
|
F23
|
Brief psychotic disorder
|
F24
|
Shared psychotic disorder
|
F25.0
|
Schizoaffective disorder, bipolar type
|
F25.1
|
Schizoaffective disorder, depressive type
|
F25.8
|
Other schizoaffective disorders
|
F25.9
|
Schizoaffective disorder, unspecified
|
F28
|
Other psychotic disorder not due to a substance or known physiological condition
|
F29
|
Unspecified psychosis not due to a substance or known physiological condition
|
F30.10
|
Manic episode without psychotic symptoms, unspecified
|
F30.11
|
Manic episode without psychotic symptoms, mild
|
F30.12
|
Manic episode without psychotic symptoms, moderate
|
F30.13
|
Manic episode, severe, without psychotic symptoms
|
F30.2
|
Manic episode, severe with psychotic symptoms
|
F30.3
|
Manic episode in partial remission
|
F30.8
|
Other manic episodes
|
F30.9
|
Manic episode, unspecified
|
F31.0
|
Bipolar disorder, current episode hypomanic
|
F31.10
|
Bipolar disorder, current episode manic without psychotic features, unspecified
|
F31.11
|
Bipolar disorder, current episode manic without psychotic features, mild
|
F31.12
|
Bipolar disorder, current episode manic without psychotic features, moderate
|
F31.13
|
Bipolar disorder, current episode manic without psychotic features, severe
|
F31.2
|
Bipolar disorder, current episode manic severe with psychotic features
|
F31.30
|
Bipolar disorder, current episode depressed, mild or moderate severity, unspecified
|
F31.31
|
Bipolar disorder, current episode depressed, mild
|
F31.32
|
Bipolar disorder, current episode depressed, moderate
|
F31.4
|
Bipolar disorder, current episode depressed, severe, without psychotic features
|
F31.5
|
Bipolar disorder, current episode depressed, severe, with psychotic features
|
F31.60
|
Bipolar disorder, current episode mixed, unspecified
|
F31.61
|
Bipolar disorder, current episode mixed, mild
|
F31.62
|
Bipolar disorder, current episode mixed, moderate
|
F31.63
|
Bipolar disorder, current episode mixed, severe, without psychotic features
|
F31.64
|
Bipolar disorder, current episode mixed, severe, with psychotic features
|
F31.70
|
Bipolar disorder, currently in remission, most recent episode unspecified
|
F31.71
|
Bipolar disorder, in partial remission, most recent episode hypomanic
|
F31.72
|
Bipolar disorder, in full remission, most recent episode hypomanic
|
F31.73
|
Bipolar disorder, in partial remission, most recent episode manic
|
F31.75
|
Bipolar disorder, in partial remission, most recent episode depressed
|
F31.77
|
Bipolar disorder, in partial remission, most recent episode mixed
|
F31.81
|
Bipolar II disorder
|
F31.89
|
Other bipolar disorder
|
F31.9
|
Bipolar disorder, unspecified
|
F32.0
|
Major depressive disorder, single episode, mild
|
F32.1
|
Major depressive disorder, single episode, moderate
|
F32.2
|
Major depressive disorder, single episode, severe without psychotic features
|
F32.3
|
Major depressive disorder, single episode, severe with psychotic features
|
F32.4
|
Major depressive disorder, single episode, in partial remission
|
F32.89
|
Other specified depressive episodes
|
F32.9
|
Major depressive disorder, single episode, unspecified
|
F33.0
|
Major depressive disorder, recurrent, mild
|
F33.1
|
Major depressive disorder, recurrent, moderate
|
F33.2
|
Major depressive disorder, recurrent severe without psychotic features
|
F33.3
|
Major depressive disorder, recurrent, severe with psychotic symptoms
|
F33.40
|
Major depressive disorder, recurrent, in remission, unspecified
|
F33.41
|
Major depressive disorder, recurrent, in partial remission
|
F33.8
|
Other recurrent depressive disorders
|
F33.9
|
Major depressive disorder, recurrent, unspecified
|
F34.81
|
Disruptive mood dysregulation disorder
|
F34.89
|
Other specified persistent mood disorders
|
F34.9
|
Persistent mood [affective] disorder, unspecified
|
F39
|
Unspecified mood [affective] disorder
|
F40.00
|
Agoraphobia, unspecified
|
F40.01
|
Agoraphobia with panic disorder
|
F40.02
|
Agoraphobia without panic disorder
|
F40.10
|
Social phobia, unspecified
|
F40.11
|
Social phobia, generalized
|
F40.210*
|
Arachnophobia
|
F40.218*
|
Other animal type phobia
|
F40.220*
|
Fear of thunderstorms
|
F40.228*
|
Other natural environment type phobia
|
F40.230*
|
Fear of blood
|
F40.231*
|
Fear of injections and transfusions
|
F40.232*
|
Fear of other medical care
|
F40.233*
|
Fear of injury
|
F40.240*
|
Claustrophobia
|
F40.241*
|
Acrophobia
|
F40.242*
|
Fear of bridges
|
F40.243*
|
Fear of flying
|
F40.248*
|
Other situational type phobia
|
F40.290*
|
Androphobia
|
F40.291*
|
Gynephobia
|
F40.298*
|
Other specified phobia
|
F40.8*
|
Other phobic anxiety disorders
|
F40.9
|
Phobic anxiety disorder, unspecified
|
F41.0
|
Panic disorder [episodic paroxysmal anxiety]
|
F41.1
|
Generalized anxiety disorder
|
F41.3
|
Other mixed anxiety disorders
|
F41.8
|
Other specified anxiety disorders
|
F41.9
|
Anxiety disorder, unspecified
|
F44.89
|
Other dissociative and conversion disorders
|
F44.9*
|
Dissociative and conversion disorder, unspecified
|
F53.1
|
Puerperal psychosis
|
F72
|
Severe intellectual disabilities
|
F73
|
Profound intellectual disabilities
|
F78.A9
|
Other genetic related intellectual disability
|
F79
|
Unspecified intellectual disabilities
|
F84.0
|
Autistic disorder
|
F84.3
|
Other childhood disintegrative disorder
|
F84.5*
|
Asperger's syndrome
|
F84.8*
|
Other pervasive developmental disorders
|
F91.9
|
Conduct disorder, unspecified
|
G06.0
|
Intracranial abscess and granuloma
|
G12.21
|
Amyotrophic lateral sclerosis
|
G12.25
|
Progressive spinal muscle atrophy
|
G20.A1*
|
Parkinson's disease without dyskinesia, without mention of fluctuations
|
G20.A2*
|
Parkinson's disease without dyskinesia, with fluctuations
|
G20.B1*
|
Parkinson's disease with dyskinesia, without mention of fluctuations
|
G20.B2*
|
Parkinson's disease with dyskinesia, with fluctuations
|
G21.11*
|
Neuroleptic induced parkinsonism
|
G21.19*
|
Other drug induced secondary parkinsonism
|
G21.2*
|
Secondary parkinsonism due to other external agents
|
G21.3*
|
Postencephalitic parkinsonism
|
G21.4*
|
Vascular parkinsonism
|
G21.8*
|
Other secondary parkinsonism
|
G21.9*
|
Secondary parkinsonism, unspecified
|
G30.0
|
Alzheimer's disease with early onset
|
G30.1
|
Alzheimer's disease with late onset
|
G30.8
|
Other Alzheimer's disease
|
G30.9
|
Alzheimer's disease, unspecified
|
G31.85
|
Corticobasal degeneration
|
G35*
|
Multiple sclerosis
|
G40.001
|
Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, with status epilepticus
|
G40.009
|
Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus
|
G40.011
|
Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, with status epilepticus
|
G40.019
|
Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus
|
G40.101
|
Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, with status epilepticus
|
G40.109
|
Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus
|
G40.111
|
Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, with status epilepticus
|
G40.119
|
Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus
|
G40.201
|
Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, with status epilepticus
|
G40.209
|
Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus
|
G40.211
|
Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, with status epilepticus
|
G40.219
|
Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus
|
G40.301
|
Generalized idiopathic epilepsy and epileptic syndromes, not intractable, with status epilepticus
|
G40.309
|
Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus
|
G40.311
|
Generalized idiopathic epilepsy and epileptic syndromes, intractable, with status epilepticus
|
G40.319
|
Generalized idiopathic epilepsy and epileptic syndromes, intractable, without status epilepticus
|
G40.A01
|
Absence epileptic syndrome, not intractable, with status epilepticus
|
G40.A09
|
Absence epileptic syndrome, not intractable, without status epilepticus
|
G40.A11
|
Absence epileptic syndrome, intractable, with status epilepticus
|
G40.A19
|
Absence epileptic syndrome, intractable, without status epilepticus
|
G40.B01
|
Juvenile myoclonic epilepsy, not intractable, with status epilepticus
|
G40.B09
|
Juvenile myoclonic epilepsy, not intractable, without status epilepticus
|
G40.B11
|
Juvenile myoclonic epilepsy, intractable, with status epilepticus
|
G40.B19
|
Juvenile myoclonic epilepsy, intractable, without status epilepticus
|
G40.401
|
Other generalized epilepsy and epileptic syndromes, not intractable, with status epilepticus
|
G40.409
|
Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus
|
G40.411
|
Other generalized epilepsy and epileptic syndromes, intractable, with status epilepticus
|
G40.419
|
Other generalized epilepsy and epileptic syndromes, intractable, without status epilepticus
|
G40.501
|
Epileptic seizures related to external causes, not intractable, with status epilepticus
|
G40.509
|
Epileptic seizures related to external causes, not intractable, without status epilepticus
|
G40.801
|
Other epilepsy, not intractable, with status epilepticus
|
G40.802
|
Other epilepsy, not intractable, without status epilepticus
|
G40.803
|
Other epilepsy, intractable, with status epilepticus
|
G40.804
|
Other epilepsy, intractable, without status epilepticus
|
G40.811
|
Lennox-Gastaut syndrome, not intractable, with status epilepticus
|
G40.812
|
Lennox-Gastaut syndrome, not intractable, without status epilepticus
|
G40.813
|
Lennox-Gastaut syndrome, intractable, with status epilepticus
|
G40.814
|
Lennox-Gastaut syndrome, intractable, without status epilepticus
|
G40.821
|
Epileptic spasms, not intractable, with status epilepticus
|
G40.822
|
Epileptic spasms, not intractable, without status epilepticus
|
G40.823
|
Epileptic spasms, intractable, with status epilepticus
|
G40.824
|
Epileptic spasms, intractable, without status epilepticus
|
G40.89
|
Other seizures
|
G40.901*
|
Epilepsy, unspecified, not intractable, with status epilepticus
|
G40.909*
|
Epilepsy, unspecified, not intractable, without status epilepticus
|
G40.911*
|
Epilepsy, unspecified, intractable, with status epilepticus
|
G40.919*
|
Epilepsy, unspecified, intractable, without status epilepticus
|
G45.0
|
Vertebro-basilar artery syndrome
|
G45.1
|
Carotid artery syndrome (hemispheric)
|
G45.2
|
Multiple and bilateral precerebral artery syndromes
|
G45.4*
|
Transient global amnesia
|
G45.8
|
Other transient cerebral ischemic attacks and related syndromes
|
G45.9
|
Transient cerebral ischemic attack, unspecified
|
G46.0
|
Middle cerebral artery syndrome
|
G46.1
|
Anterior cerebral artery syndrome
|
G46.2
|
Posterior cerebral artery syndrome
|
G46.3*
|
Brain stem stroke syndrome
|
G46.4*
|
Cerebellar stroke syndrome
|
G46.5*
|
Pure motor lacunar syndrome
|
G46.6*
|
Pure sensory lacunar syndrome
|
G46.7*
|
Other lacunar syndromes
|
G46.8*
|
Other vascular syndromes of brain in cerebrovascular diseases
|
G47.33
|
Obstructive sleep apnea (adult) (pediatric)
|
G70.00
|
Myasthenia gravis without (acute) exacerbation
|
G70.80
|
Lambert-Eaton syndrome, unspecified
|
G70.81
|
Lambert-Eaton syndrome in disease classified elsewhere
|
G73.1
|
Lambert-Eaton syndrome in neoplastic disease
|
G80.9*
|
Cerebral palsy, unspecified
|
G97.81
|
Other intraoperative complications of nervous system
|
H35.20
|
Other non-diabetic proliferative retinopathy, unspecified eye
|
H35.21
|
Other non-diabetic proliferative retinopathy, right eye
|
H35.22
|
Other non-diabetic proliferative retinopathy, left eye
|
H35.23
|
Other non-diabetic proliferative retinopathy, bilateral
|
H35.3210
|
Exudative age-related macular degeneration, right eye, stage unspecified
|
H35.3211
|
Exudative age-related macular degeneration, right eye, with active choroidal neovascularization
|
H35.3212
|
Exudative age-related macular degeneration, right eye, with inactive choroidal neovascularization
|
H35.3213
|
Exudative age-related macular degeneration, right eye, with inactive scar
|
H35.3220
|
Exudative age-related macular degeneration, left eye, stage unspecified
|
H35.3221
|
Exudative age-related macular degeneration, left eye, with active choroidal neovascularization
|
H35.3222
|
Exudative age-related macular degeneration, left eye, with inactive choroidal neovascularization
|
H35.3223
|
Exudative age-related macular degeneration, left eye, with inactive scar
|
H35.3230
|
Exudative age-related macular degeneration, bilateral, stage unspecified
|
H35.3231
|
Exudative age-related macular degeneration, bilateral, with active choroidal neovascularization
|
H35.3232
|
Exudative age-related macular degeneration, bilateral, with inactive choroidal neovascularization
|
H35.3233
|
Exudative age-related macular degeneration, bilateral, with inactive scar
|
H35.341
|
Macular cyst, hole, or pseudohole, right eye
|
H35.342
|
Macular cyst, hole, or pseudohole, left eye
|
H35.343
|
Macular cyst, hole, or pseudohole, bilateral
|
H35.349
|
Macular cyst, hole, or pseudohole, unspecified eye
|
H35.371
|
Puckering of macula, right eye
|
H35.372
|
Puckering of macula, left eye
|
H35.373
|
Puckering of macula, bilateral
|
H35.379
|
Puckering of macula, unspecified eye
|
I01.0*
|
Acute rheumatic pericarditis
|
I01.1*
|
Acute rheumatic endocarditis
|
I01.2*
|
Acute rheumatic myocarditis
|
I05.0
|
Rheumatic mitral stenosis
|
I05.1
|
Rheumatic mitral insufficiency
|
I05.2
|
Rheumatic mitral stenosis with insufficiency
|
I05.8
|
Other rheumatic mitral valve diseases
|
I05.9
|
Rheumatic mitral valve disease, unspecified
|
I08.1*
|
Rheumatic disorders of both mitral and tricuspid valves
|
I08.2*
|
Rheumatic disorders of both aortic and tricuspid valves
|
I08.3*
|
Combined rheumatic disorders of mitral, aortic and tricuspid valves
|
I08.8*
|
Other rheumatic multiple valve diseases
|
I08.9*
|
Rheumatic multiple valve disease, unspecified
|
I09.1*
|
Rheumatic diseases of endocardium, valve unspecified
|
I10*
|
Essential (primary) hypertension
|
I11.0*
|
Hypertensive heart disease with heart failure
|
I11.9*
|
Hypertensive heart disease without heart failure
|
I12.0
|
Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease
|
I12.9
|
Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
|
I13.0
|
Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
|
I13.10
|
Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
|
I13.11
|
Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease
|
I13.2
|
Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease
|
I15.0
|
Renovascular hypertension
|
I15.1
|
Hypertension secondary to other renal disorders
|
I20.0
|
Unstable angina
|
I20.1
|
Angina pectoris with documented spasm
|
I20.2
|
Refractory angina pectoris
|
I20.81
|
Angina pectoris with coronary microvascular dysfunction
|
I20.89
|
Other forms of angina pectoris
|
I20.9
|
Angina pectoris, unspecified
|
I21.01
|
ST elevation (STEMI) myocardial infarction involving left main coronary artery
|
I21.02
|
ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery
|
I21.09
|
ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall
|
I21.11
|
ST elevation (STEMI) myocardial infarction involving right coronary artery
|
I21.19
|
ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall
|
I21.21
|
ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery
|
I21.29
|
ST elevation (STEMI) myocardial infarction involving other sites
|
I21.3
|
ST elevation (STEMI) myocardial infarction of unspecified site
|
I21.4
|
Non-ST elevation (NSTEMI) myocardial infarction
|
I21.9
|
Acute myocardial infarction, unspecified
|
I21.B
|
Myocardial infarction with coronary microvascular dysfunction
|
I22.0
|
Subsequent ST elevation (STEMI) myocardial infarction of anterior wall
|
I22.1
|
Subsequent ST elevation (STEMI) myocardial infarction of inferior wall
|
I22.2
|
Subsequent non-ST elevation (NSTEMI) myocardial infarction
|
I22.8
|
Subsequent ST elevation (STEMI) myocardial infarction of other sites
|
I22.9
|
Subsequent ST elevation (STEMI) myocardial infarction of unspecified site
|
I24.0
|
Acute coronary thrombosis not resulting in myocardial infarction
|
I24.1
|
Dressler's syndrome
|
I24.81*
|
Acute coronary microvascular dysfunction
|
I24.89*
|
Other forms of acute ischemic heart disease
|
I24.9*
|
Acute ischemic heart disease, unspecified
|
I25.10
|
Atherosclerotic heart disease of native coronary artery without angina pectoris
|
I25.110
|
Atherosclerotic heart disease of native coronary artery with unstable angina pectoris
|
I25.111
|
Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm
|
I25.112
|
Atherosclerotic heart disease of native coronary artery with refractory angina pectoris
|
I25.118
|
Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris
|
I25.119
|
Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris
|
I25.2*
|
Old myocardial infarction
|
I25.3
|
Aneurysm of heart
|
I25.41
|
Coronary artery aneurysm
|
I25.42
|
Coronary artery dissection
|
I25.5*
|
Ischemic cardiomyopathy
|
I25.6*
|
Silent myocardial ischemia
|
I25.700
|
Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris
|
I25.701
|
Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris with documented spasm
|
I25.702
|
Atherosclerosis of coronary artery bypass graft(s), unspecified, with refractory angina pectoris
|
I25.708
|
Atherosclerosis of coronary artery bypass graft(s), unspecified, with other forms of angina pectoris
|
I25.710
|
Atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris
|
I25.711
|
Atherosclerosis of autologous vein coronary artery bypass graft(s) with angina pectoris with documented spasm
|
I25.712
|
Atherosclerosis of autologous vein coronary artery bypass graft(s) with refractory angina pectoris
|
I25.718
|
Atherosclerosis of autologous vein coronary artery bypass graft(s) with other forms of angina pectoris
|
I25.719
|
Atherosclerosis of autologous vein coronary artery bypass graft(s) with unspecified angina pectoris
|
I25.720
|
Atherosclerosis of autologous artery coronary artery bypass graft(s) with unstable angina pectoris
|
I25.721
|
Atherosclerosis of autologous artery coronary artery bypass graft(s) with angina pectoris with documented spasm
|
I25.722
|
Atherosclerosis of autologous artery coronary artery bypass graft(s) with refractory angina pectoris
|
I25.728
|
Atherosclerosis of autologous artery coronary artery bypass graft(s) with other forms of angina pectoris
|
I25.729
|
Atherosclerosis of autologous artery coronary artery bypass graft(s) with unspecified angina pectoris
|
I25.730
|
Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unstable angina pectoris
|
I25.731
|
Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris with documented spasm
|
I25.732
|
Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with refractory angina pectoris
|
I25.738
|
Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with other forms of angina pectoris
|
I25.739
|
Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unspecified angina pectoris
|
I25.750
|
Atherosclerosis of native coronary artery of transplanted heart with unstable angina
|
I25.751
|
Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm
|
I25.752
|
Atherosclerosis of native coronary artery of transplanted heart with refractory angina pectoris
|
I25.758
|
Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris
|
I25.759
|
Atherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris
|
I25.760
|
Atherosclerosis of bypass graft of coronary artery of transplanted heart with unstable angina
|
I25.761
|
Atherosclerosis of bypass graft of coronary artery of transplanted heart with angina pectoris with documented spasm
|
I25.762
|
Atherosclerosis of bypass graft of coronary artery of transplanted heart with refractory angina pectoris
|
I25.768
|
Atherosclerosis of bypass graft of coronary artery of transplanted heart with other forms of angina pectoris
|
I25.769
|
Atherosclerosis of bypass graft of coronary artery of transplanted heart with unspecified angina pectoris
|
I25.790
|
Atherosclerosis of other coronary artery bypass graft(s) with unstable angina pectoris
|
I25.791
|
Atherosclerosis of other coronary artery bypass graft(s) with angina pectoris with documented spasm
|
I25.792
|
Atherosclerosis of other coronary artery bypass graft(s) with refractory angina pectoris
|
I25.798
|
Atherosclerosis of other coronary artery bypass graft(s) with other forms of angina pectoris
|
I25.799
|
Atherosclerosis of other coronary artery bypass graft(s) with unspecified angina pectoris
|
I25.810
|
Atherosclerosis of coronary artery bypass graft(s) without angina pectoris
|
I25.811
|
Atherosclerosis of native coronary artery of transplanted heart without angina pectoris
|
I25.812
|
Atherosclerosis of bypass graft of coronary artery of transplanted heart without angina pectoris
|
I25.82
|
Chronic total occlusion of coronary artery
|
I25.83
|
Coronary atherosclerosis due to lipid rich plaque
|
I25.84
|
Coronary atherosclerosis due to calcified coronary lesion
|
I25.85*
|
Chronic coronary microvascular dysfunction
|
I25.89*
|
Other forms of chronic ischemic heart disease
|
I25.9*
|
Chronic ischemic heart disease, unspecified
|
I26.03
|
Cement embolism of pulmonary artery with acute cor pulmonale
|
I26.04
|
Fat embolism of pulmonary artery with acute cor pulmonale
|
I26.09
|
Other pulmonary embolism with acute cor pulmonale
|
I27.0
|
Primary pulmonary hypertension
|
I27.81*
|
Cor pulmonale (chronic)
|
I27.82
|
Chronic pulmonary embolism
|
I27.9*
|
Pulmonary heart disease, unspecified
|
I30.0
|
Acute nonspecific idiopathic pericarditis
|
I30.1
|
Infective pericarditis
|
I30.8
|
Other forms of acute pericarditis
|
I30.9
|
Acute pericarditis, unspecified
|
I31.0
|
Chronic adhesive pericarditis
|
I31.1
|
Chronic constrictive pericarditis
|
I31.2
|
Hemopericardium, not elsewhere classified
|
I31.31
|
Malignant pericardial effusion in diseases classified elsewhere
|
I31.39
|
Other pericardial effusion (noninflammatory)
|
I31.8
|
Other specified diseases of pericardium
|
I31.9
|
Disease of pericardium, unspecified
|
I32
|
Pericarditis in diseases classified elsewhere
|
I33.0
|
Acute and subacute infective endocarditis
|
I33.9
|
Acute and subacute endocarditis, unspecified
|
I34.0
|
Nonrheumatic mitral (valve) insufficiency
|
I34.1
|
Nonrheumatic mitral (valve) prolapse
|
I34.2
|
Nonrheumatic mitral (valve) stenosis
|
I34.81
|
Nonrheumatic mitral (valve) annulus calcification
|
I34.89
|
Other nonrheumatic mitral valve disorders
|
I34.9
|
Nonrheumatic mitral valve disorder, unspecified
|
I35.0
|
Nonrheumatic aortic (valve) stenosis
|
I35.1
|
Nonrheumatic aortic (valve) insufficiency
|
I35.2
|
Nonrheumatic aortic (valve) stenosis with insufficiency
|
I35.8
|
Other nonrheumatic aortic valve disorders
|
I35.9
|
Nonrheumatic aortic valve disorder, unspecified
|
I36.0
|
Nonrheumatic tricuspid (valve) stenosis
|
I36.1
|
Nonrheumatic tricuspid (valve) insufficiency
|
I36.2
|
Nonrheumatic tricuspid (valve) stenosis with insufficiency
|
I36.8
|
Other nonrheumatic tricuspid valve disorders
|
I36.9
|
Nonrheumatic tricuspid valve disorder, unspecified
|
I37.0
|
Nonrheumatic pulmonary valve stenosis
|
I37.1
|
Nonrheumatic pulmonary valve insufficiency
|
I37.2
|
Nonrheumatic pulmonary valve stenosis with insufficiency
|
I37.8
|
Other nonrheumatic pulmonary valve disorders
|
I37.9
|
Nonrheumatic pulmonary valve disorder, unspecified
|
I38*
|
Endocarditis, valve unspecified
|
I39
|
Endocarditis and heart valve disorders in diseases classified elsewhere
|
I40.0
|
Infective myocarditis
|
I40.1
|
Isolated myocarditis
|
I40.8
|
Other acute myocarditis
|
I40.9
|
Acute myocarditis, unspecified
|
I41
|
Myocarditis in diseases classified elsewhere
|
I42.0
|
Dilated cardiomyopathy
|
I42.1
|
Obstructive hypertrophic cardiomyopathy
|
I42.2
|
Other hypertrophic cardiomyopathy
|
I42.3
|
Endomyocardial (eosinophilic) disease
|
I42.4
|
Endocardial fibroelastosis
|
I42.5
|
Other restrictive cardiomyopathy
|
I42.6
|
Alcoholic cardiomyopathy
|
I42.7*
|
Cardiomyopathy due to drug and external agent
|
I42.8
|
Other cardiomyopathies
|
I42.9*
|
Cardiomyopathy, unspecified
|
I43*
|
Cardiomyopathy in diseases classified elsewhere
|
I44.0
|
Atrioventricular block, first degree
|
I44.1
|
Atrioventricular block, second degree
|
I44.2
|
Atrioventricular block, complete
|
I44.30
|
Unspecified atrioventricular block
|
I44.39
|
Other atrioventricular block
|
I44.4
|
Left anterior fascicular block
|
I44.5
|
Left posterior fascicular block
|
I44.60
|
Unspecified fascicular block
|
I44.69
|
Other fascicular block
|
I44.7
|
Left bundle-branch block, unspecified
|
I45.0
|
Right fascicular block
|
I45.10
|
Unspecified right bundle-branch block
|
I45.19
|
Other right bundle-branch block
|
I45.2
|
Bifascicular block
|
I45.3
|
Trifascicular block
|
I45.4
|
Nonspecific intraventricular block
|
I45.5
|
Other specified heart block
|
I45.6
|
Pre-excitation syndrome
|
I45.81
|
Long QT syndrome
|
I45.89
|
Other specified conduction disorders
|
I45.9*
|
Conduction disorder, unspecified
|
I46.2
|
Cardiac arrest due to underlying cardiac condition
|
I46.8
|
Cardiac arrest due to other underlying condition
|
I46.9
|
Cardiac arrest, cause unspecified
|
I47.0
|
Re-entry ventricular arrhythmia
|
I47.11
|
Inappropriate sinus tachycardia, so stated
|
I47.19
|
Other supraventricular tachycardia
|
I47.21
|
Torsades de pointes
|
I47.29
|
Other ventricular tachycardia
|
I47.9
|
Paroxysmal tachycardia, unspecified
|
I48.0
|
Paroxysmal atrial fibrillation
|
I48.11
|
Longstanding persistent atrial fibrillation
|
I48.19
|
Other persistent atrial fibrillation
|
I48.20
|
Chronic atrial fibrillation, unspecified
|
I48.21
|
Permanent atrial fibrillation
|
I48.3
|
Typical atrial flutter
|
I48.4
|
Atypical atrial flutter
|
I48.91
|
Unspecified atrial fibrillation
|
I48.92
|
Unspecified atrial flutter
|
I49.01
|
Ventricular fibrillation
|
I49.02
|
Ventricular flutter
|
I49.1
|
Atrial premature depolarization
|
I49.2
|
Junctional premature depolarization
|
I49.3
|
Ventricular premature depolarization
|
I49.40
|
Unspecified premature depolarization
|
I49.49
|
Other premature depolarization
|
I49.5
|
Sick sinus syndrome
|
I49.8*
|
Other specified cardiac arrhythmias
|
I50.1
|
Left ventricular failure, unspecified
|
I50.20
|
Unspecified systolic (congestive) heart failure
|
I50.21
|
Acute systolic (congestive) heart failure
|
I50.22
|
Chronic systolic (congestive) heart failure
|
I50.23
|
Acute on chronic systolic (congestive) heart failure
|
I50.30
|
Unspecified diastolic (congestive) heart failure
|
I50.31
|
Acute diastolic (congestive) heart failure
|
I50.32
|
Chronic diastolic (congestive) heart failure
|
I50.33
|
Acute on chronic diastolic (congestive) heart failure
|
I50.40
|
Unspecified combined systolic (congestive) and diastolic (congestive) heart failure
|
I50.41
|
Acute combined systolic (congestive) and diastolic (congestive) heart failure
|
I50.42
|
Chronic combined systolic (congestive) and diastolic (congestive) heart failure
|
I50.43
|
Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure
|
I50.810*
|
Right heart failure, unspecified
|
I50.811*
|
Acute right heart failure
|
I50.812*
|
Chronic right heart failure
|
I50.813*
|
Acute on chronic right heart failure
|
I50.814*
|
Right heart failure due to left heart failure
|
I50.82*
|
Biventricular heart failure
|
I50.83*
|
High output heart failure
|
I50.84*
|
End stage heart failure
|
I50.89*
|
Other heart failure
|
I50.9*
|
Heart failure, unspecified
|
I60.00
|
Nontraumatic subarachnoid hemorrhage from unspecified carotid siphon and bifurcation
|
I60.01
|
Nontraumatic subarachnoid hemorrhage from right carotid siphon and bifurcation
|
I60.02
|
Nontraumatic subarachnoid hemorrhage from left carotid siphon and bifurcation
|
I60.10
|
Nontraumatic subarachnoid hemorrhage from unspecified middle cerebral artery
|
I60.11
|
Nontraumatic subarachnoid hemorrhage from right middle cerebral artery
|
I60.12
|
Nontraumatic subarachnoid hemorrhage from left middle cerebral artery
|
I60.2
|
Nontraumatic subarachnoid hemorrhage from anterior communicating artery
|
I60.30
|
Nontraumatic subarachnoid hemorrhage from unspecified posterior communicating artery
|
I60.31
|
Nontraumatic subarachnoid hemorrhage from right posterior communicating artery
|
I60.32
|
Nontraumatic subarachnoid hemorrhage from left posterior communicating artery
|
I60.4
|
Nontraumatic subarachnoid hemorrhage from basilar artery
|
I60.50
|
Nontraumatic subarachnoid hemorrhage from unspecified vertebral artery
|
I60.51
|
Nontraumatic subarachnoid hemorrhage from right vertebral artery
|
I60.52
|
Nontraumatic subarachnoid hemorrhage from left vertebral artery
|
I60.6
|
Nontraumatic subarachnoid hemorrhage from other intracranial arteries
|
I60.7
|
Nontraumatic subarachnoid hemorrhage from unspecified intracranial artery
|
I60.8
|
Other nontraumatic subarachnoid hemorrhage
|
I60.9
|
Nontraumatic subarachnoid hemorrhage, unspecified
|
I61.0
|
Nontraumatic intracerebral hemorrhage in hemisphere, subcortical
|
I61.1
|
Nontraumatic intracerebral hemorrhage in hemisphere, cortical
|
I61.2
|
Nontraumatic intracerebral hemorrhage in hemisphere, unspecified
|
I61.3
|
Nontraumatic intracerebral hemorrhage in brain stem
|
I61.4
|
Nontraumatic intracerebral hemorrhage in cerebellum
|
I61.5
|
Nontraumatic intracerebral hemorrhage, intraventricular
|
I61.6
|
Nontraumatic intracerebral hemorrhage, multiple localized
|
I61.8
|
Other nontraumatic intracerebral hemorrhage
|
I61.9
|
Nontraumatic intracerebral hemorrhage, unspecified
|
I62.00
|
Nontraumatic subdural hemorrhage, unspecified
|
I62.01
|
Nontraumatic acute subdural hemorrhage
|
I62.02
|
Nontraumatic subacute subdural hemorrhage
|
I62.03
|
Nontraumatic chronic subdural hemorrhage
|
I62.1
|
Nontraumatic extradural hemorrhage
|
I63.00
|
Cerebral infarction due to thrombosis of unspecified precerebral artery
|
I63.011
|
Cerebral infarction due to thrombosis of right vertebral artery
|
I63.012
|
Cerebral infarction due to thrombosis of left vertebral artery
|
I63.013
|
Cerebral infarction due to thrombosis of bilateral vertebral arteries
|
I63.019
|
Cerebral infarction due to thrombosis of unspecified vertebral artery
|
I63.02
|
Cerebral infarction due to thrombosis of basilar artery
|
I63.031
|
Cerebral infarction due to thrombosis of right carotid artery
|
I63.032
|
Cerebral infarction due to thrombosis of left carotid artery
|
I63.033
|
Cerebral infarction due to thrombosis of bilateral carotid arteries
|
I63.039
|
Cerebral infarction due to thrombosis of unspecified carotid artery
|
I63.09
|
Cerebral infarction due to thrombosis of other precerebral artery
|
I63.10
|
Cerebral infarction due to embolism of unspecified precerebral artery
|
I63.111
|
Cerebral infarction due to embolism of right vertebral artery
|
I63.112
|
Cerebral infarction due to embolism of left vertebral artery
|
I63.113
|
Cerebral infarction due to embolism of bilateral vertebral arteries
|
I63.119
|
Cerebral infarction due to embolism of unspecified vertebral artery
|
I63.12
|
Cerebral infarction due to embolism of basilar artery
|
I63.131
|
Cerebral infarction due to embolism of right carotid artery
|
I63.132
|
Cerebral infarction due to embolism of left carotid artery
|
I63.133
|
Cerebral infarction due to embolism of bilateral carotid arteries
|
I63.139
|
Cerebral infarction due to embolism of unspecified carotid artery
|
I63.19
|
Cerebral infarction due to embolism of other precerebral artery
|
I63.20
|
Cerebral infarction due to unspecified occlusion or stenosis of unspecified precerebral arteries
|
I63.211
|
Cerebral infarction due to unspecified occlusion or stenosis of right vertebral artery
|
I63.212
|
Cerebral infarction due to unspecified occlusion or stenosis of left vertebral artery
|
I63.213
|
Cerebral infarction due to unspecified occlusion or stenosis of bilateral vertebral arteries
|
I63.219
|
Cerebral infarction due to unspecified occlusion or stenosis of unspecified vertebral artery
|
I63.22
|
Cerebral infarction due to unspecified occlusion or stenosis of basilar artery
|
I63.231
|
Cerebral infarction due to unspecified occlusion or stenosis of right carotid arteries
|
I63.232
|
Cerebral infarction due to unspecified occlusion or stenosis of left carotid arteries
|
I63.233
|
Cerebral infarction due to unspecified occlusion or stenosis of bilateral carotid arteries
|
I63.239
|
Cerebral infarction due to unspecified occlusion or stenosis of unspecified carotid artery
|
I63.29
|
Cerebral infarction due to unspecified occlusion or stenosis of other precerebral arteries
|
I63.30
|
Cerebral infarction due to thrombosis of unspecified cerebral artery
|
I63.311
|
Cerebral infarction due to thrombosis of right middle cerebral artery
|
I63.312
|
Cerebral infarction due to thrombosis of left middle cerebral artery
|
I63.313
|
Cerebral infarction due to thrombosis of bilateral middle cerebral arteries
|
I63.319
|
Cerebral infarction due to thrombosis of unspecified middle cerebral artery
|
I63.321
|
Cerebral infarction due to thrombosis of right anterior cerebral artery
|
I63.322
|
Cerebral infarction due to thrombosis of left anterior cerebral artery
|
I63.323
|
Cerebral infarction due to thrombosis of bilateral anterior cerebral arteries
|
I63.329
|
Cerebral infarction due to thrombosis of unspecified anterior cerebral artery
|
I63.331
|
Cerebral infarction due to thrombosis of right posterior cerebral artery
|
I63.332
|
Cerebral infarction due to thrombosis of left posterior cerebral artery
|
I63.333
|
Cerebral infarction due to thrombosis of bilateral posterior cerebral arteries
|
I63.339
|
Cerebral infarction due to thrombosis of unspecified posterior cerebral artery
|
I63.341
|
Cerebral infarction due to thrombosis of right cerebellar artery
|
I63.342
|
Cerebral infarction due to thrombosis of left cerebellar artery
|
I63.343
|
Cerebral infarction due to thrombosis of bilateral cerebellar arteries
|
I63.349
|
Cerebral infarction due to thrombosis of unspecified cerebellar artery
|
I63.39
|
Cerebral infarction due to thrombosis of other cerebral artery
|
I63.40
|
Cerebral infarction due to embolism of unspecified cerebral artery
|
I63.411
|
Cerebral infarction due to embolism of right middle cerebral artery
|
I63.412
|
Cerebral infarction due to embolism of left middle cerebral artery
|
I63.413
|
Cerebral infarction due to embolism of bilateral middle cerebral arteries
|
I63.419
|
Cerebral infarction due to embolism of unspecified middle cerebral artery
|
I63.421
|
Cerebral infarction due to embolism of right anterior cerebral artery
|
I63.422
|
Cerebral infarction due to embolism of left anterior cerebral artery
|
I63.423
|
Cerebral infarction due to embolism of bilateral anterior cerebral arteries
|
I63.429
|
Cerebral infarction due to embolism of unspecified anterior cerebral artery
|
I63.431
|
Cerebral infarction due to embolism of right posterior cerebral artery
|
I63.432
|
Cerebral infarction due to embolism of left posterior cerebral artery
|
I63.433
|
Cerebral infarction due to embolism of bilateral posterior cerebral arteries
|
I63.439
|
Cerebral infarction due to embolism of unspecified posterior cerebral artery
|
I63.441
|
Cerebral infarction due to embolism of right cerebellar artery
|
I63.442
|
Cerebral infarction due to embolism of left cerebellar artery
|
I63.443
|
Cerebral infarction due to embolism of bilateral cerebellar arteries
|
I63.449
|
Cerebral infarction due to embolism of unspecified cerebellar artery
|
I63.49
|
Cerebral infarction due to embolism of other cerebral artery
|
I63.50
|
Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery
|
I63.511
|
Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery
|
I63.512
|
Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery
|
I63.513
|
Cerebral infarction due to unspecified occlusion or stenosis of bilateral middle cerebral arteries
|
I63.519
|
Cerebral infarction due to unspecified occlusion or stenosis of unspecified middle cerebral artery
|
I63.521
|
Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery
|
I63.522
|
Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery
|
I63.523
|
Cerebral infarction due to unspecified occlusion or stenosis of bilateral anterior cerebral arteries
|
I63.529
|
Cerebral infarction due to unspecified occlusion or stenosis of unspecified anterior cerebral artery
|
I63.531
|
Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery
|
I63.532
|
Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery
|
I63.533
|
Cerebral infarction due to unspecified occlusion or stenosis of bilateral posterior cerebral arteries
|
I63.539
|
Cerebral infarction due to unspecified occlusion or stenosis of unspecified posterior cerebral artery
|
I63.541
|
Cerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery
|
I63.542
|
Cerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery
|
I63.543
|
Cerebral infarction due to unspecified occlusion or stenosis of bilateral cerebellar arteries
|
I63.549
|
Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebellar artery
|
I63.59
|
Cerebral infarction due to unspecified occlusion or stenosis of other cerebral artery
|
I63.6
|
Cerebral infarction due to cerebral venous thrombosis, nonpyogenic
|
I63.81
|
Other cerebral infarction due to occlusion or stenosis of small artery
|
I63.89
|
Other cerebral infarction
|
I63.9
|
Cerebral infarction, unspecified
|
I65.01
|
Occlusion and stenosis of right vertebral artery
|
I65.02
|
Occlusion and stenosis of left vertebral artery
|
I65.03
|
Occlusion and stenosis of bilateral vertebral arteries
|
I65.09
|
Occlusion and stenosis of unspecified vertebral artery
|
I65.1
|
Occlusion and stenosis of basilar artery
|
I65.21
|
Occlusion and stenosis of right carotid artery
|
I65.22
|
Occlusion and stenosis of left carotid artery
|
I65.23
|
Occlusion and stenosis of bilateral carotid arteries
|
I65.29
|
Occlusion and stenosis of unspecified carotid artery
|
I65.8
|
Occlusion and stenosis of other precerebral arteries
|
I65.9
|
Occlusion and stenosis of unspecified precerebral artery
|
I66.01
|
Occlusion and stenosis of right middle cerebral artery
|
I66.02
|
Occlusion and stenosis of left middle cerebral artery
|
I66.03
|
Occlusion and stenosis of bilateral middle cerebral arteries
|
I66.09
|
Occlusion and stenosis of unspecified middle cerebral artery
|
I66.11
|
Occlusion and stenosis of right anterior cerebral artery
|
I66.12
|
Occlusion and stenosis of left anterior cerebral artery
|
I66.13
|
Occlusion and stenosis of bilateral anterior cerebral arteries
|
I66.19
|
Occlusion and stenosis of unspecified anterior cerebral artery
|
I66.21
|
Occlusion and stenosis of right posterior cerebral artery
|
I66.22
|
Occlusion and stenosis of left posterior cerebral artery
|
I66.23
|
Occlusion and stenosis of bilateral posterior cerebral arteries
|
I66.29
|
Occlusion and stenosis of unspecified posterior cerebral artery
|
I66.3
|
Occlusion and stenosis of cerebellar arteries
|
I66.8
|
Occlusion and stenosis of other cerebral arteries
|
I66.9
|
Occlusion and stenosis of unspecified cerebral artery
|
I67.1*
|
Cerebral aneurysm, nonruptured
|
I67.2*
|
Cerebral atherosclerosis
|
I67.4*
|
Hypertensive encephalopathy
|
I67.5*
|
Moyamoya disease
|
I67.6*
|
Nonpyogenic thrombosis of intracranial venous system
|
I67.7*
|
Cerebral arteritis, not elsewhere classified
|
I67.81*
|
Acute cerebrovascular insufficiency
|
I67.82*
|
Cerebral ischemia
|
I67.841
|
Reversible cerebrovascular vasoconstriction syndrome
|
I67.848
|
Other cerebrovascular vasospasm and vasoconstriction
|
I67.89*
|
Other cerebrovascular disease
|
I67.9*
|
Cerebrovascular disease, unspecified
|
I68.0*
|
Cerebral amyloid angiopathy
|
I68.2*
|
Cerebral arteritis in other diseases classified elsewhere
|
I68.8*
|
Other cerebrovascular disorders in diseases classified elsewhere
|
J40
|
Bronchitis, not specified as acute or chronic
|
J43.0
|
Unilateral pulmonary emphysema [MacLeod's syndrome]
|
J43.1
|
Panlobular emphysema
|
J43.2
|
Centrilobular emphysema
|
J43.8
|
Other emphysema
|
J43.9
|
Emphysema, unspecified
|
J44.9
|
Chronic obstructive pulmonary disease, unspecified
|
J45.50
|
Severe persistent asthma, uncomplicated
|
J60
|
Coalworker's pneumoconiosis
|
J61
|
Pneumoconiosis due to asbestos and other mineral fibers
|
J62.0
|
Pneumoconiosis due to talc dust
|
J62.8
|
Pneumoconiosis due to other dust containing silica
|
J63.0
|
Aluminosis (of lung)
|
J63.1
|
Bauxite fibrosis (of lung)
|
J63.2
|
Berylliosis
|
J63.3
|
Graphite fibrosis (of lung)
|
J63.4
|
Siderosis
|
J63.5
|
Stannosis
|
J63.6
|
Pneumoconiosis due to other specified inorganic dusts
|
J64
|
Unspecified pneumoconiosis
|
J65
|
Pneumoconiosis associated with tuberculosis
|
J66.0
|
Byssinosis
|
J66.1
|
Flax-dressers' disease
|
J66.2
|
Cannabinosis
|
J66.8
|
Airway disease due to other specific organic dusts
|
J68.0
|
Bronchitis and pneumonitis due to chemicals, gases, fumes and vapors
|
J68.1
|
Pulmonary edema due to chemicals, gases, fumes and vapors
|
J68.2
|
Upper respiratory inflammation due to chemicals, gases, fumes and vapors, not elsewhere classified
|
J68.3
|
Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapors
|
J68.4
|
Chronic respiratory conditions due to chemicals, gases, fumes and vapors
|
J68.8
|
Other respiratory conditions due to chemicals, gases, fumes and vapors
|
J68.9
|
Unspecified respiratory condition due to chemicals, gases, fumes and vapors
|
J70.0
|
Acute pulmonary manifestations due to radiation
|
J70.1
|
Chronic and other pulmonary manifestations due to radiation
|
J70.2
|
Acute drug-induced interstitial lung disorders
|
J70.3
|
Chronic drug-induced interstitial lung disorders
|
J70.4
|
Drug-induced interstitial lung disorders, unspecified
|
J70.5
|
Respiratory conditions due to smoke inhalation
|
J70.8
|
Respiratory conditions due to other specified external agents
|
J70.9
|
Respiratory conditions due to unspecified external agent
|
J80*
|
Acute respiratory distress syndrome
|
J81.0
|
Acute pulmonary edema
|
J82.81
|
Chronic eosinophilic pneumonia
|
J82.82
|
Acute eosinophilic pneumonia
|
J82.83
|
Eosinophilic asthma
|
J82.89
|
Other pulmonary eosinophilia, not elsewhere classified
|
J85.0
|
Gangrene and necrosis of lung
|
J85.1
|
Abscess of lung with pneumonia
|
J85.2
|
Abscess of lung without pneumonia
|
J86.0
|
Pyothorax with fistula
|
J86.9
|
Pyothorax without fistula
|
J90
|
Pleural effusion, not elsewhere classified
|
J91.0
|
Malignant pleural effusion
|
J91.8
|
Pleural effusion in other conditions classified elsewhere
|
J92.0
|
Pleural plaque with presence of asbestos
|
J92.9
|
Pleural plaque without asbestos
|
J93.0
|
Spontaneous tension pneumothorax
|
J94.0
|
Chylous effusion
|
J94.1
|
Fibrothorax
|
J94.2
|
Hemothorax
|
J94.8
|
Other specified pleural conditions
|
J94.9
|
Pleural condition, unspecified
|
J95.1
|
Acute pulmonary insufficiency following thoracic surgery
|
J95.2
|
Acute pulmonary insufficiency following nonthoracic surgery
|
J95.3
|
Chronic pulmonary insufficiency following surgery
|
J95.811
|
Postprocedural pneumothorax
|
J95.812
|
Postprocedural air leak
|
J95.821
|
Acute postprocedural respiratory failure
|
J95.822
|
Acute and chronic postprocedural respiratory failure
|
J95.84
|
Transfusion-related acute lung injury (TRALI)
|
J96.00*
|
Acute respiratory failure, unspecified whether with hypoxia or hypercapnia
|
J96.01*
|
Acute respiratory failure with hypoxia
|
J96.02*
|
Acute respiratory failure with hypercapnia
|
J96.20
|
Acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia
|
J96.21
|
Acute and chronic respiratory failure with hypoxia
|
J96.22
|
Acute and chronic respiratory failure with hypercapnia
|
J96.90*
|
Respiratory failure, unspecified, unspecified whether with hypoxia or hypercapnia
|
J96.91*
|
Respiratory failure, unspecified with hypoxia
|
J96.92*
|
Respiratory failure, unspecified with hypercapnia
|
J98.11
|
Atelectasis
|
J98.19
|
Other pulmonary collapse
|
J98.2
|
Interstitial emphysema
|
J98.3
|
Compensatory emphysema
|
K70.0
|
Alcoholic fatty liver
|
K70.10
|
Alcoholic hepatitis without ascites
|
K70.11
|
Alcoholic hepatitis with ascites
|
K70.2
|
Alcoholic fibrosis and sclerosis of liver
|
K70.30
|
Alcoholic cirrhosis of liver without ascites
|
K70.31
|
Alcoholic cirrhosis of liver with ascites
|
K70.40
|
Alcoholic hepatic failure without coma
|
K70.9
|
Alcoholic liver disease, unspecified
|
K72.00
|
Acute and subacute hepatic failure without coma
|
K72.10
|
Chronic hepatic failure without coma
|
K72.90
|
Hepatic failure, unspecified without coma
|
K72.91
|
Hepatic failure, unspecified with coma
|
K73.0
|
Chronic persistent hepatitis, not elsewhere classified
|
K73.1
|
Chronic lobular hepatitis, not elsewhere classified
|
K73.2
|
Chronic active hepatitis, not elsewhere classified
|
K73.8
|
Other chronic hepatitis, not elsewhere classified
|
K73.9
|
Chronic hepatitis, unspecified
|
K74.01
|
Hepatic fibrosis, early fibrosis
|
K74.02
|
Hepatic fibrosis, advanced fibrosis
|
K74.3
|
Primary biliary cirrhosis
|
K74.4
|
Secondary biliary cirrhosis
|
K74.5
|
Biliary cirrhosis, unspecified
|
K74.60
|
Unspecified cirrhosis of liver
|
K74.69
|
Other cirrhosis of liver
|
K75.0
|
Abscess of liver
|
K75.1
|
Phlebitis of portal vein
|
K75.4
|
Autoimmune hepatitis
|
K75.81
|
Nonalcoholic steatohepatitis (NASH)
|
K76.0
|
Fatty (change of) liver, not elsewhere classified
|
K76.2
|
Central hemorrhagic necrosis of liver
|
K76.6
|
Portal hypertension
|
K76.7
|
Hepatorenal syndrome
|
K76.89
|
Other specified diseases of liver
|
K85.00*
|
Idiopathic acute pancreatitis without necrosis or infection
|
K85.01*
|
Idiopathic acute pancreatitis with uninfected necrosis
|
K85.02*
|
Idiopathic acute pancreatitis with infected necrosis
|
K85.10*
|
Biliary acute pancreatitis without necrosis or infection
|
K85.11*
|
Biliary acute pancreatitis with uninfected necrosis
|
K85.12*
|
Biliary acute pancreatitis with infected necrosis
|
K85.20*
|
Alcohol induced acute pancreatitis without necrosis or infection
|
K85.21*
|
Alcohol induced acute pancreatitis with uninfected necrosis
|
K85.22*
|
Alcohol induced acute pancreatitis with infected necrosis
|
K85.30*
|
Drug induced acute pancreatitis without necrosis or infection
|
K85.31*
|
Drug induced acute pancreatitis with uninfected necrosis
|
K85.32*
|
Drug induced acute pancreatitis with infected necrosis
|
K85.80*
|
Other acute pancreatitis without necrosis or infection
|
K85.81*
|
Other acute pancreatitis with uninfected necrosis
|
K85.82*
|
Other acute pancreatitis with infected necrosis
|
K85.90*
|
Acute pancreatitis without necrosis or infection, unspecified
|
K85.91*
|
Acute pancreatitis with uninfected necrosis, unspecified
|
K85.92*
|
Acute pancreatitis with infected necrosis, unspecified
|
K86.0*
|
Alcohol-induced chronic pancreatitis
|
K86.1*
|
Other chronic pancreatitis
|
K92.2*
|
Gastrointestinal hemorrhage, unspecified
|
N17.0
|
Acute kidney failure with tubular necrosis
|
N17.1
|
Acute kidney failure with acute cortical necrosis
|
N17.2
|
Acute kidney failure with medullary necrosis
|
N17.8
|
Other acute kidney failure
|
N17.9
|
Acute kidney failure, unspecified
|
N18.4
|
Chronic kidney disease, stage 4 (severe)
|
N18.5
|
Chronic kidney disease, stage 5
|
N18.6
|
End stage renal disease
|
N19*
|
Unspecified kidney failure
|
N26.2
|
Page kidney
|
Q21.11
|
Secundum atrial septal defect
|
Q21.12
|
Patent foramen ovale
|
Q21.13
|
Coronary sinus atrial septal defect
|
Q21.14
|
Superior sinus venosus atrial septal defect
|
Q21.15
|
Inferior sinus venosus atrial septal defect
|
Q21.16
|
Sinus venosus atrial septal defect, unspecified
|
Q21.19
|
Other specified atrial septal defect
|
R00.1*
|
Bradycardia, unspecified
|
R06.1
|
Stridor
|
R09.1
|
Pleurisy
|
R44.0*
|
Auditory hallucinations
|
R44.2*
|
Other hallucinations
|
R44.3*
|
Hallucinations, unspecified
|
R56.00
|
Simple febrile convulsions
|
R56.01
|
Complex febrile convulsions
|
R56.1
|
Post traumatic seizures
|
R56.9*
|
Unspecified convulsions
|
R57.0
|
Cardiogenic shock
|
R57.1*
|
Hypovolemic shock
|
R57.8*
|
Other shock
|
R57.9
|
Shock, unspecified
|
R65.21
|
Severe sepsis with septic shock
|
T36.0X5A
|
Adverse effect of penicillins, initial encounter
|
T36.0X5D
|
Adverse effect of penicillins, subsequent encounter
|
T36.0X5S
|
Adverse effect of penicillins, sequela
|
T36.1X5A
|
Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter
|
T36.1X5D
|
Adverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounter
|
T36.1X5S
|
Adverse effect of cephalosporins and other beta-lactam antibiotics, sequela
|
T36.2X5A
|
Adverse effect of chloramphenicol group, initial encounter
|
T36.2X5D
|
Adverse effect of chloramphenicol group, subsequent encounter
|
T36.2X5S
|
Adverse effect of chloramphenicol group, sequela
|
T36.3X5A
|
Adverse effect of macrolides, initial encounter
|
T36.3X5D
|
Adverse effect of macrolides, subsequent encounter
|
T36.3X5S
|
Adverse effect of macrolides, sequela
|
T36.4X5A
|
Adverse effect of tetracyclines, initial encounter
|
T36.4X5D
|
Adverse effect of tetracyclines, subsequent encounter
|
T36.4X5S
|
Adverse effect of tetracyclines, sequela
|
T36.5X5A
|
Adverse effect of aminoglycosides, initial encounter
|
T36.5X5D
|
Adverse effect of aminoglycosides, subsequent encounter
|
T36.5X5S
|
Adverse effect of aminoglycosides, sequela
|
T36.6X5A
|
Adverse effect of rifampicins, initial encounter
|
T36.6X5D
|
Adverse effect of rifampicins, subsequent encounter
|
T36.6X5S
|
Adverse effect of rifampicins, sequela
|
T36.7X5A
|
Adverse effect of antifungal antibiotics, systemically used, initial encounter
|
T36.7X5D
|
Adverse effect of antifungal antibiotics, systemically used, subsequent encounter
|
T36.7X5S
|
Adverse effect of antifungal antibiotics, systemically used, sequela
|
T36.8X5A
|
Adverse effect of other systemic antibiotics, initial encounter
|
T36.8X5D
|
Adverse effect of other systemic antibiotics, subsequent encounter
|
T36.8X5S
|
Adverse effect of other systemic antibiotics, sequela
|
T36.95XA
|
Adverse effect of unspecified systemic antibiotic, initial encounter
|
T36.95XD
|
Adverse effect of unspecified systemic antibiotic, subsequent encounter
|
T36.95XS
|
Adverse effect of unspecified systemic antibiotic, sequela
|
T37.0X5A
|
Adverse effect of sulfonamides, initial encounter
|
T37.0X5D
|
Adverse effect of sulfonamides, subsequent encounter
|
T37.0X5S
|
Adverse effect of sulfonamides, sequela
|
T37.1X5A
|
Adverse effect of antimycobacterial drugs, initial encounter
|
T37.1X5D
|
Adverse effect of antimycobacterial drugs, subsequent encounter
|
T37.1X5S
|
Adverse effect of antimycobacterial drugs, sequela
|
T37.2X5A
|
Adverse effect of antimalarials and drugs acting on other blood protozoa, initial encounter
|
T37.2X5D
|
Adverse effect of antimalarials and drugs acting on other blood protozoa, subsequent encounter
|
T37.2X5S
|
Adverse effect of antimalarials and drugs acting on other blood protozoa, sequela
|
T37.3X5A
|
Adverse effect of other antiprotozoal drugs, initial encounter
|
T37.3X5D
|
Adverse effect of other antiprotozoal drugs, subsequent encounter
|
T37.3X5S
|
Adverse effect of other antiprotozoal drugs, sequela
|
T37.4X5A
|
Adverse effect of anthelminthics, initial encounter
|
T37.4X5D
|
Adverse effect of anthelminthics, subsequent encounter
|
T37.4X5S
|
Adverse effect of anthelminthics, sequela
|
T37.5X5A
|
Adverse effect of antiviral drugs, initial encounter
|
T37.5X5D
|
Adverse effect of antiviral drugs, subsequent encounter
|
T37.5X5S
|
Adverse effect of antiviral drugs, sequela
|
T37.8X5A
|
Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter
|
T37.8X5D
|
Adverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounter
|
T37.8X5S
|
Adverse effect of other specified systemic anti-infectives and antiparasitics, sequela
|
T37.95XA
|
Adverse effect of unspecified systemic anti-infective and antiparasitic, initial encounter
|
T37.95XD
|
Adverse effect of unspecified systemic anti-infective and antiparasitic, subsequent encounter
|
T37.95XS
|
Adverse effect of unspecified systemic anti-infective and antiparasitic, sequela
|
T38.0X5A
|
Adverse effect of glucocorticoids and synthetic analogues, initial encounter
|
T38.0X5D
|
Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter
|
T38.0X5S
|
Adverse effect of glucocorticoids and synthetic analogues, sequela
|
T38.1X5A
|
Adverse effect of thyroid hormones and substitutes, initial encounter
|
T38.1X5D
|
Adverse effect of thyroid hormones and substitutes, subsequent encounter
|
T38.1X5S
|
Adverse effect of thyroid hormones and substitutes, sequela
|
T38.2X5A
|
Adverse effect of antithyroid drugs, initial encounter
|
T38.2X5D
|
Adverse effect of antithyroid drugs, subsequent encounter
|
T38.2X5S
|
Adverse effect of antithyroid drugs, sequela
|
T38.4X5A
|
Adverse effect of oral contraceptives, initial encounter
|
T38.4X5D
|
Adverse effect of oral contraceptives, subsequent encounter
|
T38.4X5S
|
Adverse effect of oral contraceptives, sequela
|
T38.5X5A
|
Adverse effect of other estrogens and progestogens, initial encounter
|
T38.5X5D
|
Adverse effect of other estrogens and progestogens, subsequent encounter
|
T38.5X5S
|
Adverse effect of other estrogens and progestogens, sequela
|
T38.6X5A
|
Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter
|
T38.6X5D
|
Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter
|
T38.6X5S
|
Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela
|
T38.7X5A
|
Adverse effect of androgens and anabolic congeners, initial encounter
|
T38.7X5D
|
Adverse effect of androgens and anabolic congeners, subsequent encounter
|
T38.7X5S
|
Adverse effect of androgens and anabolic congeners, sequela
|
T38.805A
|
Adverse effect of unspecified hormones and synthetic substitutes, initial encounter
|
T38.805D
|
Adverse effect of unspecified hormones and synthetic substitutes, subsequent encounter
|
T38.805S
|
Adverse effect of unspecified hormones and synthetic substitutes, sequela
|
T38.815A
|
Adverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounter
|
T38.815D
|
Adverse effect of anterior pituitary [adenohypophyseal] hormones, subsequent encounter
|
T38.815S
|
Adverse effect of anterior pituitary [adenohypophyseal] hormones, sequela
|
T38.895A
|
Adverse effect of other hormones and synthetic substitutes, initial encounter
|
T38.895D
|
Adverse effect of other hormones and synthetic substitutes, subsequent encounter
|
T38.895S
|
Adverse effect of other hormones and synthetic substitutes, sequela
|
T38.905A
|
Adverse effect of unspecified hormone antagonists, initial encounter
|
T38.905D
|
Adverse effect of unspecified hormone antagonists, subsequent encounter
|
T38.905S
|
Adverse effect of unspecified hormone antagonists, sequela
|
T38.995A
|
Adverse effect of other hormone antagonists, initial encounter
|
T38.995D
|
Adverse effect of other hormone antagonists, subsequent encounter
|
T38.995S
|
Adverse effect of other hormone antagonists, sequela
|
T39.015A
|
Adverse effect of aspirin, initial encounter
|
T39.015D
|
Adverse effect of aspirin, subsequent encounter
|
T39.015S
|
Adverse effect of aspirin, sequela
|
T39.095A
|
Adverse effect of salicylates, initial encounter
|
T39.095D
|
Adverse effect of salicylates, subsequent encounter
|
T39.095S
|
Adverse effect of salicylates, sequela
|
T39.1X5A
|
Adverse effect of 4-Aminophenol derivatives, initial encounter
|
T39.1X5D
|
Adverse effect of 4-Aminophenol derivatives, subsequent encounter
|
T39.1X5S
|
Adverse effect of 4-Aminophenol derivatives, sequela
|
T39.2X5A
|
Adverse effect of pyrazolone derivatives, initial encounter
|
T39.2X5D
|
Adverse effect of pyrazolone derivatives, subsequent encounter
|
T39.2X5S
|
Adverse effect of pyrazolone derivatives, sequela
|
T39.315A
|
Adverse effect of propionic acid derivatives, initial encounter
|
T39.315D
|
Adverse effect of propionic acid derivatives, subsequent encounter
|
T39.315S
|
Adverse effect of propionic acid derivatives, sequela
|
T39.395A
|
Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
|
T39.395D
|
Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
|
T39.395S
|
Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela
|
T39.4X5A
|
Adverse effect of antirheumatics, not elsewhere classified, initial encounter
|
T39.4X5D
|
Adverse effect of antirheumatics, not elsewhere classified, subsequent encounter
|
T39.4X5S
|
Adverse effect of antirheumatics, not elsewhere classified, sequela
|
T39.8X5A
|
Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
|
T39.8X5D
|
Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter
|
T39.8X5S
|
Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela
|
T39.95XA
|
Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
|
T39.95XD
|
Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter
|
T39.95XS
|
Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela
|
T40.0X5A
|
Adverse effect of opium, initial encounter
|
T40.0X5D
|
Adverse effect of opium, subsequent encounter
|
T40.0X5S
|
Adverse effect of opium, sequela
|
T40.2X5A
|
Adverse effect of other opioids, initial encounter
|
T40.2X5D
|
Adverse effect of other opioids, subsequent encounter
|
T40.2X5S
|
Adverse effect of other opioids, sequela
|
T40.3X5A
|
Adverse effect of methadone, initial encounter
|
T40.3X5D
|
Adverse effect of methadone, subsequent encounter
|
T40.3X5S
|
Adverse effect of methadone, sequela
|
T40.495A
|
Adverse effect of other synthetic narcotics, initial encounter
|
T40.495D
|
Adverse effect of other synthetic narcotics, subsequent encounter
|
T40.495S
|
Adverse effect of other synthetic narcotics, sequela
|
T40.5X5A
|
Adverse effect of cocaine, initial encounter
|
T40.5X5D
|
Adverse effect of cocaine, subsequent encounter
|
T40.5X5S
|
Adverse effect of cocaine, sequela
|
T40.605A
|
Adverse effect of unspecified narcotics, initial encounter
|
T40.605D
|
Adverse effect of unspecified narcotics, subsequent encounter
|
T40.605S
|
Adverse effect of unspecified narcotics, sequela
|
T40.695A
|
Adverse effect of other narcotics, initial encounter
|
T40.695D
|
Adverse effect of other narcotics, subsequent encounter
|
T40.695S
|
Adverse effect of other narcotics, sequela
|
T40.715A
|
Adverse effect of cannabis, initial encounter
|
T40.715D
|
Adverse effect of cannabis, subsequent encounter
|
T40.715S
|
Adverse effect of cannabis, sequela
|
T40.905A
|
Adverse effect of unspecified psychodysleptics [hallucinogens], initial encounter
|
T40.905D
|
Adverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounter
|
T40.905S
|
Adverse effect of unspecified psychodysleptics [hallucinogens], sequela
|
T40.995A
|
Adverse effect of other psychodysleptics [hallucinogens], initial encounter
|
T40.995D
|
Adverse effect of other psychodysleptics [hallucinogens], subsequent encounter
|
T40.995S
|
Adverse effect of other psychodysleptics [hallucinogens], sequela
|
T41.0X5A
|
Adverse effect of inhaled anesthetics, initial encounter
|
T41.0X5D
|
Adverse effect of inhaled anesthetics, subsequent encounter
|
T41.0X5S
|
Adverse effect of inhaled anesthetics, sequela
|
T41.1X5A
|
Adverse effect of intravenous anesthetics, initial encounter
|
T41.1X5D
|
Adverse effect of intravenous anesthetics, subsequent encounter
|
T41.1X5S
|
Adverse effect of intravenous anesthetics, sequela
|
T41.205A
|
Adverse effect of unspecified general anesthetics, initial encounter
|
T41.205D
|
Adverse effect of unspecified general anesthetics, subsequent encounter
|
T41.205S
|
Adverse effect of unspecified general anesthetics, sequela
|
T41.295A
|
Adverse effect of other general anesthetics, initial encounter
|
T41.295D
|
Adverse effect of other general anesthetics, subsequent encounter
|
T41.295S
|
Adverse effect of other general anesthetics, sequela
|
T41.3X5A
|
Adverse effect of local anesthetics, initial encounter
|
T41.3X5D
|
Adverse effect of local anesthetics, subsequent encounter
|
T41.3X5S
|
Adverse effect of local anesthetics, sequela
|
T41.45XA
|
Adverse effect of unspecified anesthetic, initial encounter
|
T41.45XD
|
Adverse effect of unspecified anesthetic, subsequent encounter
|
T41.45XS
|
Adverse effect of unspecified anesthetic, sequela
|
T41.5X5A
|
Adverse effect of therapeutic gases, initial encounter
|
T41.5X5D
|
Adverse effect of therapeutic gases, subsequent encounter
|
T41.5X5S
|
Adverse effect of therapeutic gases, sequela
|
T42.0X5A
|
Adverse effect of hydantoin derivatives, initial encounter
|
T42.0X5D
|
Adverse effect of hydantoin derivatives, subsequent encounter
|
T42.0X5S
|
Adverse effect of hydantoin derivatives, sequela
|
T42.1X5A
|
Adverse effect of iminostilbenes, initial encounter
|
T42.1X5D
|
Adverse effect of iminostilbenes, subsequent encounter
|
T42.1X5S
|
Adverse effect of iminostilbenes, sequela
|
T42.2X5A
|
Adverse effect of succinimides and oxazolidinediones, initial encounter
|
T42.2X5D
|
Adverse effect of succinimides and oxazolidinediones, subsequent encounter
|
T42.2X5S
|
Adverse effect of succinimides and oxazolidinediones, sequela
|
T42.3X5A
|
Adverse effect of barbiturates, initial encounter
|
T42.3X5D
|
Adverse effect of barbiturates, subsequent encounter
|
T42.3X5S
|
Adverse effect of barbiturates, sequela
|
T42.4X5A
|
Adverse effect of benzodiazepines, initial encounter
|
T42.4X5D
|
Adverse effect of benzodiazepines, subsequent encounter
|
T42.4X5S
|
Adverse effect of benzodiazepines, sequela
|
T42.5X5A
|
Adverse effect of mixed antiepileptics, initial encounter
|
T42.5X5D
|
Adverse effect of mixed antiepileptics, subsequent encounter
|
T42.5X5S
|
Adverse effect of mixed antiepileptics, sequela
|
T42.6X5A
|
Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter
|
T42.6X5D
|
Adverse effect of other antiepileptic and sedative-hypnotic drugs, subsequent encounter
|
T42.6X5S
|
Adverse effect of other antiepileptic and sedative-hypnotic drugs, sequela
|
T42.75XA
|
Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter
|
T42.75XD
|
Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter
|
T42.75XS
|
Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, sequela
|
T42.8X5A
|
Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
|
T42.8X5D
|
Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter
|
T42.8X5S
|
Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela
|
T43.015A
|
Adverse effect of tricyclic antidepressants, initial encounter
|
T43.015D
|
Adverse effect of tricyclic antidepressants, subsequent encounter
|
T43.015S
|
Adverse effect of tricyclic antidepressants, sequela
|
T43.025A
|
Adverse effect of tetracyclic antidepressants, initial encounter
|
T43.025D
|
Adverse effect of tetracyclic antidepressants, subsequent encounter
|
T43.025S
|
Adverse effect of tetracyclic antidepressants, sequela
|
T43.1X5A
|
Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter
|
T43.1X5D
|
Adverse effect of monoamine-oxidase-inhibitor antidepressants, subsequent encounter
|
T43.1X5S
|
Adverse effect of monoamine-oxidase-inhibitor antidepressants, sequela
|
T43.205A
|
Adverse effect of unspecified antidepressants, initial encounter
|
T43.205D
|
Adverse effect of unspecified antidepressants, subsequent encounter
|
T43.205S
|
Adverse effect of unspecified antidepressants, sequela
|
T43.215A
|
Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
|
T43.215D
|
Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter
|
T43.215S
|
Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequela
|
T43.225A
|
Adverse effect of selective serotonin reuptake inhibitors, initial encounter
|
T43.225D
|
Adverse effect of selective serotonin reuptake inhibitors, subsequent encounter
|
T43.225S
|
Adverse effect of selective serotonin reuptake inhibitors, sequela
|
T43.295A
|
Adverse effect of other antidepressants, initial encounter
|
T43.295D
|
Adverse effect of other antidepressants, subsequent encounter
|
T43.295S
|
Adverse effect of other antidepressants, sequela
|
T43.3X5A
|
Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter
|
T43.3X5D
|
Adverse effect of phenothiazine antipsychotics and neuroleptics, subsequent encounter
|
T43.3X5S
|
Adverse effect of phenothiazine antipsychotics and neuroleptics, sequela
|
T43.4X5A
|
Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter
|
T43.4X5D
|
Adverse effect of butyrophenone and thiothixene neuroleptics, subsequent encounter
|
T43.4X5S
|
Adverse effect of butyrophenone and thiothixene neuroleptics, sequela
|
T43.505A
|
Adverse effect of unspecified antipsychotics and neuroleptics, initial encounter
|
T43.505D
|
Adverse effect of unspecified antipsychotics and neuroleptics, subsequent encounter
|
T43.505S
|
Adverse effect of unspecified antipsychotics and neuroleptics, sequela
|
T43.595A
|
Adverse effect of other antipsychotics and neuroleptics, initial encounter
|
T43.595D
|
Adverse effect of other antipsychotics and neuroleptics, subsequent encounter
|
T43.595S
|
Adverse effect of other antipsychotics and neuroleptics, sequela
|
T43.605A
|
Adverse effect of unspecified psychostimulants, initial encounter
|
T43.605D
|
Adverse effect of unspecified psychostimulants, subsequent encounter
|
T43.605S
|
Adverse effect of unspecified psychostimulants, sequela
|
T43.615A
|
Adverse effect of caffeine, initial encounter
|
T43.615D
|
Adverse effect of caffeine, subsequent encounter
|
T43.615S
|
Adverse effect of caffeine, sequela
|
T43.625A
|
Adverse effect of amphetamines, initial encounter
|
T43.625D
|
Adverse effect of amphetamines, subsequent encounter
|
T43.625S
|
Adverse effect of amphetamines, sequela
|
T43.635A
|
Adverse effect of methylphenidate, initial encounter
|
T43.635D
|
Adverse effect of methylphenidate, subsequent encounter
|
T43.635S
|
Adverse effect of methylphenidate, sequela
|
T43.695A
|
Adverse effect of other psychostimulants, initial encounter
|
T43.695D
|
Adverse effect of other psychostimulants, subsequent encounter
|
T43.695S
|
Adverse effect of other psychostimulants, sequela
|
T43.8X5A
|
Adverse effect of other psychotropic drugs, initial encounter
|
T43.8X5D
|
Adverse effect of other psychotropic drugs, subsequent encounter
|
T43.8X5S
|
Adverse effect of other psychotropic drugs, sequela
|
T43.95XA
|
Adverse effect of unspecified psychotropic drug, initial encounter
|
T43.95XD
|
Adverse effect of unspecified psychotropic drug, subsequent encounter
|
T43.95XS
|
Adverse effect of unspecified psychotropic drug, sequela
|
T44.0X5A
|
Adverse effect of anticholinesterase agents, initial encounter
|
T44.0X5D
|
Adverse effect of anticholinesterase agents, subsequent encounter
|
T44.0X5S
|
Adverse effect of anticholinesterase agents, sequela
|
T44.1X5A
|
Adverse effect of other parasympathomimetics [cholinergics], initial encounter
|
T44.1X5D
|
Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter
|
T44.1X5S
|
Adverse effect of other parasympathomimetics [cholinergics], sequela
|
T44.2X5A
|
Adverse effect of ganglionic blocking drugs, initial encounter
|
T44.2X5D
|
Adverse effect of ganglionic blocking drugs, subsequent encounter
|
T44.2X5S
|
Adverse effect of ganglionic blocking drugs, sequela
|
T44.3X5A
|
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
|
T44.3X5D
|
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
|
T44.3X5S
|
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
|
T44.4X5A
|
Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter
|
T44.4X5D
|
Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter
|
T44.4X5S
|
Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela
|
T44.5X5A
|
Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter
|
T44.5X5D
|
Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter
|
T44.5X5S
|
Adverse effect of predominantly beta-adrenoreceptor agonists, sequela
|
T44.6X5A
|
Adverse effect of alpha-adrenoreceptor antagonists, initial encounter
|
T44.6X5D
|
Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter
|
T44.6X5S
|
Adverse effect of alpha-adrenoreceptor antagonists, sequela
|
T44.7X5A
|
Adverse effect of beta-adrenoreceptor antagonists, initial encounter
|
T44.7X5D
|
Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter
|
T44.7X5S
|
Adverse effect of beta-adrenoreceptor antagonists, sequela
|
T44.8X5A
|
Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
|
T44.8X5D
|
Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter
|
T44.8X5S
|
Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela
|
T44.905A
|
Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter
|
T44.905D
|
Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter
|
T44.905S
|
Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela
|
T45.0X5A
|
Adverse effect of antiallergic and antiemetic drugs, initial encounter
|
T45.0X5D
|
Adverse effect of antiallergic and antiemetic drugs, subsequent encounter
|
T45.0X5S
|
Adverse effect of antiallergic and antiemetic drugs, sequela
|
T45.1X5A
|
Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
|
T45.1X5D
|
Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
|
T45.1X5S
|
Adverse effect of antineoplastic and immunosuppressive drugs, sequela
|
T45.2X5A
|
Adverse effect of vitamins, initial encounter
|
T45.2X5D
|
Adverse effect of vitamins, subsequent encounter
|
T45.2X5S
|
Adverse effect of vitamins, sequela
|
T45.3X5A
|
Adverse effect of enzymes, initial encounter
|
T45.3X5D
|
Adverse effect of enzymes, subsequent encounter
|
T45.3X5S
|
Adverse effect of enzymes, sequela
|
T45.4X5A
|
Adverse effect of iron and its compounds, initial encounter
|
T45.4X5D
|
Adverse effect of iron and its compounds, subsequent encounter
|
T45.4X5S
|
Adverse effect of iron and its compounds, sequela
|
T45.515A
|
Adverse effect of anticoagulants, initial encounter
|
T45.515D
|
Adverse effect of anticoagulants, subsequent encounter
|
T45.515S
|
Adverse effect of anticoagulants, sequela
|
T45.525A
|
Adverse effect of antithrombotic drugs, initial encounter
|
T45.525D
|
Adverse effect of antithrombotic drugs, subsequent encounter
|
T45.525S
|
Adverse effect of antithrombotic drugs, sequela
|
T45.605A
|
Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter
|
T45.605D
|
Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter
|
T45.605S
|
Adverse effect of unspecified fibrinolysis-affecting drugs, sequela
|
T45.615A
|
Adverse effect of thrombolytic drugs, initial encounter
|
T45.615D
|
Adverse effect of thrombolytic drugs, subsequent encounter
|
T45.615S
|
Adverse effect of thrombolytic drugs, sequela
|
T45.625A
|
Adverse effect of hemostatic drug, initial encounter
|
T45.625D
|
Adverse effect of hemostatic drug, subsequent encounter
|
T45.625S
|
Adverse effect of hemostatic drug, sequela
|
T45.695A
|
Adverse effect of other fibrinolysis-affecting drugs, initial encounter
|
T45.695D
|
Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter
|
T45.695S
|
Adverse effect of other fibrinolysis-affecting drugs, sequela
|
T45.7X5A
|
Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
|
T45.7X5D
|
Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter
|
T45.7X5S
|
Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela
|
T45.8X5A
|
Adverse effect of other primarily systemic and hematological agents, initial encounter
|
T45.8X5D
|
Adverse effect of other primarily systemic and hematological agents, subsequent encounter
|
T45.8X5S
|
Adverse effect of other primarily systemic and hematological agents, sequela
|
T45.95XA
|
Adverse effect of unspecified primarily systemic and hematological agent, initial encounter
|
T45.95XD
|
Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter
|
T45.95XS
|
Adverse effect of unspecified primarily systemic and hematological agent, sequela
|
T46.0X5A
|
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
|
T46.0X5D
|
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
|
T46.0X5S
|
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
|
T46.1X5A
|
Adverse effect of calcium-channel blockers, initial encounter
|
T46.1X5D
|
Adverse effect of calcium-channel blockers, subsequent encounter
|
T46.1X5S
|
Adverse effect of calcium-channel blockers, sequela
|
T46.2X5A
|
Adverse effect of other antidysrhythmic drugs, initial encounter
|
T46.2X5D
|
Adverse effect of other antidysrhythmic drugs, subsequent encounter
|
T46.2X5S
|
Adverse effect of other antidysrhythmic drugs, sequela
|
T46.3X5A
|
Adverse effect of coronary vasodilators, initial encounter
|
T46.3X5D
|
Adverse effect of coronary vasodilators, subsequent encounter
|
T46.3X5S
|
Adverse effect of coronary vasodilators, sequela
|
T46.4X5A
|
Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
|
T46.4X5D
|
Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
|
T46.4X5S
|
Adverse effect of angiotensin-converting-enzyme inhibitors, sequela
|
T46.5X5A
|
Adverse effect of other antihypertensive drugs, initial encounter
|
T46.5X5D
|
Adverse effect of other antihypertensive drugs, subsequent encounter
|
T46.5X5S
|
Adverse effect of other antihypertensive drugs, sequela
|
T46.6X5A
|
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
|
T46.6X5D
|
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
|
T46.6X5S
|
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
|
T46.7X5A
|
Adverse effect of peripheral vasodilators, initial encounter
|
T46.7X5D
|
Adverse effect of peripheral vasodilators, subsequent encounter
|
T46.7X5S
|
Adverse effect of peripheral vasodilators, sequela
|
T46.8X5A
|
Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter
|
T46.8X5D
|
Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
|
T46.8X5S
|
Adverse effect of antivaricose drugs, including sclerosing agents, sequela
|
T46.905A
|
Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
|
T46.905D
|
Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
|
T46.905S
|
Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
|
T46.995A
|
Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter
|
T46.995D
|
Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
|
T46.995S
|
Adverse effect of other agents primarily affecting the cardiovascular system, sequela
|
T47.0X5A
|
Adverse effect of histamine H2-receptor blockers, initial encounter
|
T47.0X5D
|
Adverse effect of histamine H2-receptor blockers, subsequent encounter
|
T47.0X5S
|
Adverse effect of histamine H2-receptor blockers, sequela
|
T47.1X5A
|
Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
|
T47.1X5D
|
Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter
|
T47.1X5S
|
Adverse effect of other antacids and anti-gastric-secretion drugs, sequela
|
T47.2X5A
|
Adverse effect of stimulant laxatives, initial encounter
|
T47.2X5D
|
Adverse effect of stimulant laxatives, subsequent encounter
|
T47.2X5S
|
Adverse effect of stimulant laxatives, sequela
|
T47.3X5A
|
Adverse effect of saline and osmotic laxatives, initial encounter
|
T47.3X5D
|
Adverse effect of saline and osmotic laxatives, subsequent encounter
|
T47.3X5S
|
Adverse effect of saline and osmotic laxatives, sequela
|
T47.4X5A
|
Adverse effect of other laxatives, initial encounter
|
T47.4X5D
|
Adverse effect of other laxatives, subsequent encounter
|
T47.4X5S
|
Adverse effect of other laxatives, sequela
|
T47.5X5A
|
Adverse effect of digestants, initial encounter
|
T47.5X5D
|
Adverse effect of digestants, subsequent encounter
|
T47.5X5S
|
Adverse effect of digestants, sequela
|
T47.6X5A
|
Adverse effect of antidiarrheal drugs, initial encounter
|
T47.6X5D
|
Adverse effect of antidiarrheal drugs, subsequent encounter
|
T47.6X5S
|
Adverse effect of antidiarrheal drugs, sequela
|
T47.7X5A
|
Adverse effect of emetics, initial encounter
|
T47.7X5D
|
Adverse effect of emetics, subsequent encounter
|
T47.7X5S
|
Adverse effect of emetics, sequela
|
T47.8X5A
|
Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter
|
T47.8X5D
|
Adverse effect of other agents primarily affecting gastrointestinal system, subsequent encounter
|
T47.8X5S
|
Adverse effect of other agents primarily affecting gastrointestinal system, sequela
|
T47.95XA
|
Adverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter
|
T47.95XD
|
Adverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter
|
T47.95XS
|
Adverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela
|
T48.0X5A
|
Adverse effect of oxytocic drugs, initial encounter
|
T48.0X5D
|
Adverse effect of oxytocic drugs, subsequent encounter
|
T48.0X5S
|
Adverse effect of oxytocic drugs, sequela
|
T48.1X5A
|
Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
|
T48.1X5D
|
Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter
|
T48.1X5S
|
Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela
|
T48.205A
|
Adverse effect of unspecified drugs acting on muscles, initial encounter
|
T48.205D
|
Adverse effect of unspecified drugs acting on muscles, subsequent encounter
|
T48.205S
|
Adverse effect of unspecified drugs acting on muscles, sequela
|
T48.295A
|
Adverse effect of other drugs acting on muscles, initial encounter
|
T48.295D
|
Adverse effect of other drugs acting on muscles, subsequent encounter
|
T48.295S
|
Adverse effect of other drugs acting on muscles, sequela
|
T48.3X5A
|
Adverse effect of antitussives, initial encounter
|
T48.3X5D
|
Adverse effect of antitussives, subsequent encounter
|
T48.3X5S
|
Adverse effect of antitussives, sequela
|
T48.4X5A
|
Adverse effect of expectorants, initial encounter
|
T48.4X5D
|
Adverse effect of expectorants, subsequent encounter
|
T48.4X5S
|
Adverse effect of expectorants, sequela
|
T48.5X5A
|
Adverse effect of other anti-common-cold drugs, initial encounter
|
T48.5X5D
|
Adverse effect of other anti-common-cold drugs, subsequent encounter
|
T48.5X5S
|
Adverse effect of other anti-common-cold drugs, sequela
|
T48.6X5A
|
Adverse effect of antiasthmatics, initial encounter
|
T48.6X5D
|
Adverse effect of antiasthmatics, subsequent encounter
|
T48.6X5S
|
Adverse effect of antiasthmatics, sequela
|
T48.905A
|
Adverse effect of unspecified agents primarily acting on the respiratory system, initial encounter
|
T48.905D
|
Adverse effect of unspecified agents primarily acting on the respiratory system, subsequent encounter
|
T48.905S
|
Adverse effect of unspecified agents primarily acting on the respiratory system, sequela
|
T48.995A
|
Adverse effect of other agents primarily acting on the respiratory system, initial encounter
|
T48.995D
|
Adverse effect of other agents primarily acting on the respiratory system, subsequent encounter
|
T48.995S
|
Adverse effect of other agents primarily acting on the respiratory system, sequela
|
T49.0X5A
|
Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
|
T49.0X5D
|
Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
|
T49.0X5S
|
Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela
|
T49.1X5A
|
Adverse effect of antipruritics, initial encounter
|
T49.1X5D
|
Adverse effect of antipruritics, subsequent encounter
|
T49.1X5S
|
Adverse effect of antipruritics, sequela
|
T49.2X5A
|
Adverse effect of local astringents and local detergents, initial encounter
|
T49.2X5D
|
Adverse effect of local astringents and local detergents, subsequent encounter
|
T49.2X5S
|
Adverse effect of local astringents and local detergents, sequela
|
T49.3X5A
|
Adverse effect of emollients, demulcents and protectants, initial encounter
|
T49.3X5D
|
Adverse effect of emollients, demulcents and protectants, subsequent encounter
|
T49.3X5S
|
Adverse effect of emollients, demulcents and protectants, sequela
|
T49.4X5A
|
Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
|
T49.4X5D
|
Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter
|
T49.4X5S
|
Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela
|
T49.5X5A
|
Adverse effect of ophthalmological drugs and preparations, initial encounter
|
T49.5X5D
|
Adverse effect of ophthalmological drugs and preparations, subsequent encounter
|
T49.5X5S
|
Adverse effect of ophthalmological drugs and preparations, sequela
|
T49.6X5A
|
Adverse effect of otorhinolaryngological drugs and preparations, initial encounter
|
T49.6X5D
|
Adverse effect of otorhinolaryngological drugs and preparations, subsequent encounter
|
T49.6X5S
|
Adverse effect of otorhinolaryngological drugs and preparations, sequela
|
T49.7X5A
|
Adverse effect of dental drugs, topically applied, initial encounter
|
T49.7X5D
|
Adverse effect of dental drugs, topically applied, subsequent encounter
|
T49.7X5S
|
Adverse effect of dental drugs, topically applied, sequela
|
T49.8X5A
|
Adverse effect of other topical agents, initial encounter
|
T49.8X5D
|
Adverse effect of other topical agents, subsequent encounter
|
T49.8X5S
|
Adverse effect of other topical agents, sequela
|
T49.95XA
|
Adverse effect of unspecified topical agent, initial encounter
|
T49.95XD
|
Adverse effect of unspecified topical agent, subsequent encounter
|
T49.95XS
|
Adverse effect of unspecified topical agent, sequela
|
T50.0X5A
|
Adverse effect of mineralocorticoids and their antagonists, initial encounter
|
T50.0X5D
|
Adverse effect of mineralocorticoids and their antagonists, subsequent encounter
|
T50.0X5S
|
Adverse effect of mineralocorticoids and their antagonists, sequela
|
T50.1X5A
|
Adverse effect of loop [high-ceiling] diuretics, initial encounter
|
T50.1X5D
|
Adverse effect of loop [high-ceiling] diuretics, subsequent encounter
|
T50.1X5S
|
Adverse effect of loop [high-ceiling] diuretics, sequela
|
T50.2X5A
|
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
|
T50.2X5D
|
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
|
T50.2X5S
|
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
|
T50.3X5A
|
Adverse effect of electrolytic, caloric and water-balance agents, initial encounter
|
T50.3X5D
|
Adverse effect of electrolytic, caloric and water-balance agents, subsequent encounter
|
T50.3X5S
|
Adverse effect of electrolytic, caloric and water-balance agents, sequela
|
T50.4X5A
|
Adverse effect of drugs affecting uric acid metabolism, initial encounter
|
T50.4X5D
|
Adverse effect of drugs affecting uric acid metabolism, subsequent encounter
|
T50.4X5S
|
Adverse effect of drugs affecting uric acid metabolism, sequela
|
T50.5X5A
|
Adverse effect of appetite depressants, initial encounter
|
T50.5X5D
|
Adverse effect of appetite depressants, subsequent encounter
|
T50.5X5S
|
Adverse effect of appetite depressants, sequela
|
T50.6X5A
|
Adverse effect of antidotes and chelating agents, initial encounter
|
T50.6X5D
|
Adverse effect of antidotes and chelating agents, subsequent encounter
|
T50.6X5S
|
Adverse effect of antidotes and chelating agents, sequela
|
T50.7X5A
|
Adverse effect of analeptics and opioid receptor antagonists, initial encounter
|
T50.7X5D
|
Adverse effect of analeptics and opioid receptor antagonists, subsequent encounter
|
T50.7X5S
|
Adverse effect of analeptics and opioid receptor antagonists, sequela
|
T50.8X5A
|
Adverse effect of diagnostic agents, initial encounter
|
T50.8X5D
|
Adverse effect of diagnostic agents, subsequent encounter
|
T50.8X5S
|
Adverse effect of diagnostic agents, sequela
|
T50.A15A
|
Adverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounter
|
T50.A15D
|
Adverse effect of pertussis vaccine, including combinations with a pertussis component, subsequent encounter
|
T50.A15S
|
Adverse effect of pertussis vaccine, including combinations with a pertussis component, sequela
|
T50.A25A
|
Adverse effect of mixed bacterial vaccines without a pertussis component, initial encounter
|
T50.A25D
|
Adverse effect of mixed bacterial vaccines without a pertussis component, subsequent encounter
|
T50.A25S
|
Adverse effect of mixed bacterial vaccines without a pertussis component, sequela
|
T50.A95A
|
Adverse effect of other bacterial vaccines, initial encounter
|
T50.A95D
|
Adverse effect of other bacterial vaccines, subsequent encounter
|
T50.A95S
|
Adverse effect of other bacterial vaccines, sequela
|
T50.B15A
|
Adverse effect of smallpox vaccines, initial encounter
|
T50.B15D
|
Adverse effect of smallpox vaccines, subsequent encounter
|
T50.B15S
|
Adverse effect of smallpox vaccines, sequela
|
T50.B95A
|
Adverse effect of other viral vaccines, initial encounter
|
T50.B95D
|
Adverse effect of other viral vaccines, subsequent encounter
|
T50.B95S
|
Adverse effect of other viral vaccines, sequela
|
T50.Z15A
|
Adverse effect of immunoglobulin, initial encounter
|
T50.Z15D
|
Adverse effect of immunoglobulin, subsequent encounter
|
T50.Z15S
|
Adverse effect of immunoglobulin, sequela
|
T50.Z95A
|
Adverse effect of other vaccines and biological substances, initial encounter
|
T50.Z95D
|
Adverse effect of other vaccines and biological substances, subsequent encounter
|
T50.Z95S
|
Adverse effect of other vaccines and biological substances, sequela
|
T50.905A
|
Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter
|
T50.905D
|
Adverse effect of unspecified drugs, medicaments and biological substances, subsequent encounter
|
T50.905S
|
Adverse effect of unspecified drugs, medicaments and biological substances, sequela
|
T50.995A
|
Adverse effect of other drugs, medicaments and biological substances, initial encounter
|
T50.995D
|
Adverse effect of other drugs, medicaments and biological substances, subsequent encounter
|
T50.995S
|
Adverse effect of other drugs, medicaments and biological substances, sequela
|
T78.00XA
|
Anaphylactic reaction due to unspecified food, initial encounter
|
T78.00XD
|
Anaphylactic reaction due to unspecified food, subsequent encounter
|
T78.00XS
|
Anaphylactic reaction due to unspecified food, sequela
|
T78.01XA
|
Anaphylactic reaction due to peanuts, initial encounter
|
T78.01XD
|
Anaphylactic reaction due to peanuts, subsequent encounter
|
T78.01XS
|
Anaphylactic reaction due to peanuts, sequela
|
T78.02XA
|
Anaphylactic reaction due to shellfish (crustaceans), initial encounter
|
T78.02XD
|
Anaphylactic reaction due to shellfish (crustaceans), subsequent encounter
|
T78.02XS
|
Anaphylactic reaction due to shellfish (crustaceans), sequela
|
T78.03XA
|
Anaphylactic reaction due to other fish, initial encounter
|
T78.03XD
|
Anaphylactic reaction due to other fish, subsequent encounter
|
T78.03XS
|
Anaphylactic reaction due to other fish, sequela
|
T78.04XA
|
Anaphylactic reaction due to fruits and vegetables, initial encounter
|
T78.04XD
|
Anaphylactic reaction due to fruits and vegetables, subsequent encounter
|
T78.04XS
|
Anaphylactic reaction due to fruits and vegetables, sequela
|
T78.05XA
|
Anaphylactic reaction due to tree nuts and seeds, initial encounter
|
T78.05XD
|
Anaphylactic reaction due to tree nuts and seeds, subsequent encounter
|
T78.05XS
|
Anaphylactic reaction due to tree nuts and seeds, sequela
|
T78.06XA
|
Anaphylactic reaction due to food additives, initial encounter
|
T78.06XD
|
Anaphylactic reaction due to food additives, subsequent encounter
|
T78.06XS
|
Anaphylactic reaction due to food additives, sequela
|
T78.07XA
|
Anaphylactic reaction due to milk and dairy products, initial encounter
|
T78.07XD
|
Anaphylactic reaction due to milk and dairy products, subsequent encounter
|
T78.07XS
|
Anaphylactic reaction due to milk and dairy products, sequela
|
T78.08XA
|
Anaphylactic reaction due to eggs, initial encounter
|
T78.08XD
|
Anaphylactic reaction due to eggs, subsequent encounter
|
T78.08XS
|
Anaphylactic reaction due to eggs, sequela
|
T78.09XA
|
Anaphylactic reaction due to other food products, initial encounter
|
T78.09XD
|
Anaphylactic reaction due to other food products, subsequent encounter
|
T78.09XS
|
Anaphylactic reaction due to other food products, sequela
|
T78.2XXA
|
Anaphylactic shock, unspecified, initial encounter
|
T78.2XXD
|
Anaphylactic shock, unspecified, subsequent encounter
|
T78.2XXS
|
Anaphylactic shock, unspecified, sequela
|
T78.3XXA
|
Angioneurotic edema, initial encounter
|
T78.3XXD
|
Angioneurotic edema, subsequent encounter
|
T78.3XXS
|
Angioneurotic edema, sequela
|
T78.40XA
|
Allergy, unspecified, initial encounter
|
T78.40XD
|
Allergy, unspecified, subsequent encounter
|
T78.40XS
|
Allergy, unspecified, sequela
|
T78.41XA
|
Arthus phenomenon, initial encounter
|
T78.41XD
|
Arthus phenomenon, subsequent encounter
|
T78.41XS
|
Arthus phenomenon, sequela
|
T78.49XA
|
Other allergy, initial encounter
|
T78.49XD
|
Other allergy, subsequent encounter
|
T78.49XS
|
Other allergy, sequela
|
T81.81XA
|
Complication of inhalation therapy, initial encounter
|
T81.81XD
|
Complication of inhalation therapy, subsequent encounter
|
T81.81XS
|
Complication of inhalation therapy, sequela
|
T81.9XXA
|
Unspecified complication of procedure, initial encounter
|
T81.9XXD
|
Unspecified complication of procedure, subsequent encounter
|
T81.9XXS
|
Unspecified complication of procedure, sequela
|
T88.2XXA
|
Shock due to anesthesia, initial encounter
|
T88.2XXD
|
Shock due to anesthesia, subsequent encounter
|
T88.2XXS
|
Shock due to anesthesia, sequela
|
T88.4XXA
|
Failed or difficult intubation, initial encounter
|
T88.4XXD
|
Failed or difficult intubation, subsequent encounter
|
T88.4XXS
|
Failed or difficult intubation, sequela
|
T88.52XA
|
Failed moderate sedation during procedure, initial encounter
|
T88.52XD
|
Failed moderate sedation during procedure, subsequent encounter
|
T88.52XS
|
Failed moderate sedation during procedure, sequela
|
T88.59XA
|
Other complications of anesthesia, initial encounter
|
T88.59XD
|
Other complications of anesthesia, subsequent encounter
|
T88.59XS
|
Other complications of anesthesia, sequela
|
T88.6XXA
|
Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered, initial encounter
|
T88.6XXD
|
Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered, subsequent encounter
|
T88.6XXS
|
Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered, sequela
|
T88.7XXA
|
Unspecified adverse effect of drug or medicament, initial encounter
|
T88.7XXD
|
Unspecified adverse effect of drug or medicament, subsequent encounter
|
T88.7XXS
|
Unspecified adverse effect of drug or medicament, sequela
|
T88.8XXA
|
Other specified complications of surgical and medical care, not elsewhere classified, initial encounter
|
T88.8XXD
|
Other specified complications of surgical and medical care, not elsewhere classified, subsequent encounter
|
T88.8XXS
|
Other specified complications of surgical and medical care, not elsewhere classified, sequela
|
T88.9XXA
|
Complication of surgical and medical care, unspecified, initial encounter
|
T88.9XXD
|
Complication of surgical and medical care, unspecified, subsequent encounter
|
T88.9XXS
|
Complication of surgical and medical care, unspecified, sequela
|
Z79.3*
|
Long term (current) use of hormonal contraceptives
|
Z79.891*
|
Long term (current) use of opiate analgesic
|
Z79.899*
|
Other long term (current) drug therapy
|
Z88.4
|
Allergy status to anesthetic agent
|
Z88.5
|
Allergy status to narcotic agent
|
Z88.6
|
Allergy status to analgesic agent
|
Z92.83
|
Personal history of failed moderate sedation
|
Z93.0
|
Tracheostomy status
|
Z99.81
|
Dependence on supplemental oxygen
|